References

ADAEC (American Diabetes Association Expert Committee), Report of the Expert Committee on the diagnosis and Classification of diabetes mellitus. Diabetes Care 20: 1183, 1997.

Adams LS, Seeram NP, Aggai"wal BB, Takada Y, Sand D, Heber D; Pornegi'anate juice, total pomegranate ellagitannins, and punicalagiti suppress intlammatory cell signaling in colon cancer cells. Journal of Agi'icultural Food Chemistry 54(3):980-985, 2006.

Adamson I, Okafor C: A supplement of dikanut (Irvingia gabonemis) improves treatment of type II diabetics. West African Journal of Medicine 9; 108-115, 1990.

Afac] F, Arshi M, Deeba S, Daniel M, Mary SM, Hasan M: Pomegranate fruit extract modulates UV- B-inediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes. Pholochemistry and Photobiology 81(1); 38-45, 2005.

Afaq F, Mohammad S, Christian GK, Jess DR, Hasan M: Anthocyanin- and hydrolyzable tannin-rich pomegi'anate fruit extract modulates MAPK and NF-kappaB pathways and inliibits skin tvimorigenesis in CD-I mice. International Journal of Cancer 113(3); 423-433, 2005a.

Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF: Phosphorylation of Ser̂ °̂ in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. Journal of B iological Chemistry 277; 1531-1537, 2002.

Ahmad F, Azevedo JL, Cortright R, Dohm GL, Goldstein BJ; Alterations in skeletal muscle protein- tyi'osine phosphatase activity and expression in insulin-resistant human obesity and diabetes, Jomiial of Clinical Investigation 100:449-458, 1997,

Ahmad F, Li PM, Meyerovitch J, Goldstein BJ, Osmotic loading of neutralizing antibodies defines a role for protein tyi'osine phosphatase IB in negative regulation of the insulin action pathway. Journal of Biological Chemistry 270; 20503, 1995,

Ahmad S, Wang N, Bin Hafeez B, Cheruvu VK, Haqqi TM: Ptmiea granalim L, e.xtract inhibits IL- Ip -induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-F1 B in human chondrocytes in vitro. Journal of Nutrition 135(9): 2096-2102, 2005.

Ahren B, Larsson H, Wilhelmsson C, Nasman B, Olsson T: Regulation of circulating leptin in humans. Endocrine 7: 1-8, 1997.

Ahren B, Scheurir\k AJ; Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice. European Journal of Endocrinology 139: 461-467,1998.

Ajaikimiar KB, Asheef M, Babu BH, Padikkala J: The inhibition of gastric mucosal injury by Punica gmnatiim L. (pomegranate) methanolic extract. Journal of Ethnopharmacology 96(1-2): 171-176,2005.

Ajit kar, Choudhary BK, Bandhopadhyay NG: Preliminary studies on the inorganic constituents of some indigenous hypoglycemic herbs on oral glucose tolerance test. Journal of Ethnopharmacology 64; 179-184, 1999,

e Alcimoto K, Takahashi R, Moriya S, Nishioka N, Takayanagi J, Kiraura K, Fukui Y, Osada S, Mizuno K, Hirai S, Kazlauskas A, Ohno S: EMBO Journal 15: 788, 1996.

® Alarcon-Aguilar, FJ, Ramos, RR Flores Saenz JL: Plantas Medicinales usadas en el control de la diabetes mellitus. Ciencia 44; 363-361,1993.

8 Alarcon-A.gxiilara FJ, Roman-Rarnos R, Perez-Gutienez S, Aguilar-Contreras A, Contreras-Weber CC, Flores-Saenz JL; Study of the anti-hyperglycemic effect of plants used as antidiabetics. Journal of Ethnopharmacology 61 (2); 101-110, 1998.

® Albrecht MA, .liang W, Kumi DJ, Lansky EP, Goramersall LM, Patel A, Mansel RE, Neeman 1, Geldof AA, Campbell MJ; Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. Journal of Medicinal Food 7(3); 274-283, 2004.

9 Alford FP, Martin FIR, Pearson MJ: Significance and inteipretation o f mildly abnormal oral glucose tolerance test. Diabetalogia 7: 173-180,1971.

s Ali, M; Techniques in terpenoid identification, Birla publications. (Regd.), Delhi,. 2001.

® Allison J, McClive P, Oxbrow L: Genetic requirements for acceleration of diabetes in rion-obesediabetic mice expressing interleukin-2 in islet beta-cells. European .fournal of Immunology 24; 2535,1994.

a American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997.Diabetes Care 21; 296-309, 1998.

® Amos A, McCarty D, Zimmet P; The rising global burden of diabetes and its complications; estimatesand projections to the year 2010. Diabetic Med. 14; S1-S85, 1997.

s Anderson JW, Akanji AO: Dietary fiber-an ovemew. Diabetes care 14; 1126-1131, 1991.

® AngLilo P; Non alcoholic fatty liver disease. New England Journal of Medicine 346: 1221-1231, 2002.

® Asauo 'f, SMbasaki Y, Kasuga M, Kanazav/a Y, Takaku F,, Akanuma Y, Oka Y; Cloning of a rabbitbrain glucose transporter cDNA and alteration of glucose transporter mRNA during tissue development. Biochemical and Biophysical Research Communications 154:1204-1211, 1988.

® Asano T, Takaku F, Oka Y: The nucleotide sequence of cDNA for a mouse liver-type glucosetransport protein. Nucleic Acids Research 17: 6386,1989.

® Atkinson MA, Bowman MA, Campbell L. Cellular immunity to a determinant common to glutamatedecarboxylase and coxsackie virus in insulin dependant diabetes mellitus. .lournal o f Clinical Investigation 94, 2125,1994.

® Atkinson M, Leiter EH; The NOD mouse model of insulin dependant diabetes mellitus as good as itgets? Nature Medicine 5: 601,1999.

® Aviram M, Dornfeld L, Kaplan M, Coleman R, Gaitini D, Nitecki S, Hofman A, Rosenblat M,Volkova N, Presser D, Attias J, Hayek T, Fuhrman B: Pomegranate juice flavonoides inhibit low- density lipoprotein oxidation and cardiovascular diseases; studies in atherosclerotic mice and in humans. Drugs under Experimental and Clinical Research 28; 49-62, 2002.

9 Azadzoi KM, Schulman RN, Avirani M, Siroky MB; Oxidative stress in arteriogenic erectile dysfunction; prophylactic role of antioxidants. Journal of Urology, 174(1): 386-393, 2005.

» Bagdade JD, Porte D, Bierman, EL: Acute insulin withdrawal and the regulation of plasmatriglyceride removal in diabetic subjects. Diabetes 17; 127-130, 1968.

o Balasa B, Krahl T, Patstone G; CD40 ligand and CD40 interactions are necessary for the initiation o f insulitis and diabetes in nonobese diabetic mice. .Journal of Immunology 1.59: 4620, 1997.

a Balasse EO, Bier DM, Havel RJ; Early effects of antiinsulin serum on hepatic metabolism of plasma Iree fatty acids in dogs. Diabetes 21; 280-284, 1972.

® Bandyopadhyay G, Sajan MP, Kanoh Y, Standaert ML, Quon M.T, Lea-Currie R, Sen A, Farese RV; PKC-{zeta} Mediates Insulin Effects on Glucose Transport in Cultured Preadipocyte-Derived Human Adipocytes. Journal of Clinical Endocrinology and Metabolism 87: 716-723, 2002.

® Bandyopadhyay G, Standaert ML, Galloway L, Moscat J, Farese RV; Evidence for Involvement ofProtein Kinase C (PKC)-C and Noninvolvement of Diacylglycerol-Sensitive PKCs in Insulin- Stimulated Glucose Transport in L6 Myotubes. Endocrinology 138; 4721-4731, 1997.

e Barthel A, Schmoll D; Novel concepts in insulin regulation of hepatic gluconeogenesis. American .Fournal of Physiology, Endocrinology and Metabolism 285; E685-E692, 2003.

e Basso LV, Havel RJ: Hepatic metabolism of free fatty acids in normal and diabetic dogs. Journal of Clinical Investigation 49; 537-541, 1970.

e Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shigematsu S, Biekel PE, Pessin JE, Saltiel AR; CAP defmes a second signalling pathway required for insulin-stimulated glucose transport. Nature 407; 202-207, 2000.

a Bennet PH; Epidemiology of type 2 diabetes mellitus. In: Diabetes Mellitus, A Fundamental andClinical Text, LeRoith D, Taylor SI, Olefsky .IM, (Eds.) 2'“' Edition, Lippincott Williams & Wilkins,Philadelphia, USA, pp. 544-548, 2000.

e Bennett RA, Pegg AE: Alkylafion of DNA in rat tissues following administration of streptozotocin.Cancer Research 41: 2786-2790, 1981,

e> Berg AH, Combs TP, Du X, Brownlee M, Scherer PE; The adipocyte-secreted protein Acrp30enhances hepatic insulin action. Nature Medicine 7; 947-953, 2001.

® Bergman B, Haskins K; Islet-specific T-cell clones of the NOD-mouse respond to B-granule. antigen.Diabetes 43; 197, 1994.

® Betteridge DJ; Diabetic dyslipidemia. American Journal of Medicine (Suppl.6A) 96; 25S-3 IS, 1994.

® Betteridge J; Lipid disorders in diabetes mellitus, in: Pickup JC, Wiliams G. (Eds.) Textbook ofDiabetes, sec. Ond ed., Blackwell Science, London; PP, (31), 1- 55. 1997.

® Bingley PJ, Bonifacio E, Gale EAM. Perspectives in diabetes. Can we really predict IDDM? Diabetes 42,213,1993.

Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Botazzo GF, Gale EA: Prediction oflDUM in the general: strategies based on combination of autoantibody markers. Diabetes 46: 185, 1997.

Birk OS, Douek DC, Elias D: A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model. Proceedings of National Academy of Science USA 93; 1032, 1996.

Bjorbaek C, Echwald SM, Hubricht P; Genetic variants in promoters and coding regions of the muscle glycogen synthase and the insulin responsive GLUT4 genes in NIDDM. Diabetes 43: 976- 983, 1995.

Bjornholra M, Kavvano Y, Lehtihet M, Zierath JR: hisulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46: 524-527, 1997.

Blondel O, Bailbe D, Portha B: Relation of insulin deficiency to impaired insulin action in NIDDM adult rats given streptozotocin as neonates. Diabetes 38: 610-617, 1989.

Bonadonna RC, del Prato S, Bonora E, Gulli G, Solini A, DeFronzo RA: Effects of physiological hyperinsulinemia on the intracellular metabolic partition of plasma glucose. American Journal of Physiology 265: 943-953, 1993.

Bonnier-Vv^eir S, Trent DE, Honey RN, Weir GC: Response to neonatal islets to streptozotocin: Limited p cell regeneration and hyperglycaemia. Diabetes 30: 64-69, 1981.

Braiman L, Alt A, Kuroki T, Ohba M, Bak A, Temienbauni T, Sampson SR: Protein Kinase CS Mediates Insulin-Induced Glucose Transport in Primary Cultures of Rat Skeletal Muscle. Molecular Endocrinology 13: 2002-2012, 1999.

Broca C, Gross R, Petit P, Sauvaire Y, Manteghetti M, Toumier M, Masiello P, Goniis R, Ribes G: 4- Flydroxyisoleucine : experimental evidence of its insulinotropie and anti diabetic properties. American Journal ofPhysiology (Endocrinology and Metabolism) 277: E617-E623, 1999.

Brown GB, Xue-Qiao, Sacco DE, Alberts JJ: Lipid lowering and plaque regression. New insiglits into prevention o f plaque disruption and clinical events in coronary disease. Circulation 87: 1781-1791, 1993.

Brown MS, Goldstein JL: In Harrisons’ Principles of Internal'Medicine, eds. Isselbacher -KJ, Braunwald E. McGraw Hill Inc, International Edition, pp.2068, 1994.

Bruce DG, Chisholm DJ, Storiien LH, Kraegen EW, Smythe GA: The effects of sympathetic nervous system activation and psychological stress on glucose metabolism and blood pressure in subjects with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35: 835-43, 1992.

Buren J, Liu H, Eriksson JW: Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-ldnase and protein kinase B in primary cultured rat adipocytes. European Journal of Endocrinology 146: 419- 429, 2002.

Burkart V, Wang ZQ, Radons J; Mice lacking poly (ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destl^lction and diabetes development induced by streptozotocin. Nature Medicine 5: 314, 1999.

® Byrne MM, Gliem K,, Wank U, Arnold R, Katschinski M, Polonsky KS, Goke B: Glucagon-likepeptide 1 improves the ability of the b-cell to sense and respond to glucose in subjects with impaired glucose tolerance. Diabetes 47: 1259-1265, 1998.

® Campfield LA, Smith FJ, Bum P: Strategies and Potential Molccular Targets for Obesity Treatment. Science 280; 1383-1387, 1998.

e Carey JO, A 2evedo JL, Morris PG, Pories W.I, Dohm GL: Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deox,yglucose transport in insulin-resistant human skeletal muscle. Diabetes 44: 682-688, 1995.

® Caro JF, Sinha MK, Raju SM, Itloop 0 , Pories WJ, Flickinger EG, Meelheim D, Dohm GL: Insulinreceptor kinase in human skeletal muscle from obese subjects with and without non-insulin dependant diabetes mellitus. Journal Clinical Investigation 79: 1330-1337, 1987.

® Chalkley SM, Hettiarachchi M, Chisholm D.I, Kraegen EW: Five-hour fatty acid elevation increasesmuscle lipids and impairs glycogen synthesis in the rat. Metabolism 47: 1121-1126, 1998.

e Champsaur H, Bottazzo G, Bertrams J: Virologic, imimmologic and genetic factors in insulin-dependant diabetes mellitus. Journal of Pediatrics 100: 15, 1982.

® Chang L, Adams RD, Saltiel AR: The TC 10-interacting protein CIP4/2 is required for insulin-stimulated Glut4 translocation in 3T3L1 adipocytes. Proceedings of National Academy o f Science USA 99: 12835-12840, 2002.

® Charron MC, Brosius FC, Alper S, Lodish HF: A glucose transport protein expressed predominantlyin insulin-responsive tissues, Proceedings of National Academy of Science USA 86: 2535-2539,1989.

® Chase PH, Glasgow AM: Juvenile diabetes mellitus and semm lipids and lipoprotein levels.American Journal of Diseases of Child 130: 1113, 1976.

® Chauhan D, Chauhan JS: Flavonoid diglycoside from Pimica granatum. Pharmaceutical .Biology39(2): 155-157, 2001.

® Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR: Phosphatidylinositol 3-ldnaseactivation is required for insulin stimulation of pp70 s6 kinase, dna-synthesis, and glucose-transporter translocation. Molecular and Cellular Biology 14 (7): 4902-4911,1994.

® Cheetham B, Kahn CR: Insulin action and insulin signaling network. Endocrine Reviews 16 (2): 117-142, 1995.

® Chen H, Wertheimer SJ, Lin Lin CH: protein tyrosine phosphatases FTP IB and Syp are modulatorsof insulin-stimulated translocation of glut4 in transfected rat adipose cells. Jovmtal of Biological Chemistry 272: 8026, 1997.

® Cheng JT, Liu IM, Clii TC, Tzeng TF, Lu FH, Chang CJ: Plasma Glucose-Lowering Effect ofTramadol ui Streptozotocin-Induced Diabetic Rats. Diabetes 50: 2815-2821, 2001.

e Cherrington AD, Fuchs H, Stevenson RW, Williams PE, Alberti KG, Steiner KE: Effect of epinephrine on glycogenolysis and gluconeogenesis in conscious overnight fasted dogs. American Jonrnal of Physiology 247: 137-144, 1984.

s Cho H, Mu J, Kim JK, Thorvaldsen J, Chu LQ, Crenshaw EB, tCaestner KII, Bartolomei MS, Shulman GI, Birnbaum MJ: Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBP). Science 292: 1728-1731, 2001.

® Choi CS, Lee FN, Youn JH: Free Fatty Acids Induce Peripheral Insulin Resistance Without Increasing Muscle Hexosamine Pathway. Diabetes 50: 418, 2001.

® Christianson SW, Shultz LD, Leiter EH. Adoptive transfer of diabetes into inununodeficient NOD sdcl/scid mice: relative to contributors of CD4+ and CD8+ T- cells from diabetic versus prediabetic NOD.NON-fV-j"' donors. Diabetes 42, 44, 1993.

® Christie MR: Islet cell autoantigens in type 1 diabetes. European Journal of Clinical Investigation 26: 827, 1996.

® Chua SCJ, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, Leibel RL: Phenotypes ofMouse diabetes and KiA fatty Due to Mutations in the OB (Leptin) Receptor. Science 271; 994-996,1996.

e Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gounnelen M, Dina C, Chambaz J,Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B: A mutation in thehuman leptin receptor gene causes obesity and pituitary dysfunction. Nature 392: 398-401, 1998.

9 Coimbra TC, Danni FF, Blotta RM, da Periara CA, Guedes MD, Graf RG: Plants employed in thetreatment of diabetes mellitus; results of an ethnopharmacological survey in Porto Alegre, Brazil. Fitoterapia 63: 320-322, .1992. '

® Coleman DL: Obese and diabetes; two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14; 141-148, 1978.

® Condonelli G, Vigliotta G, lavorone C: PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO Journal 17: 3858-3866, 1997.

® Coppack SW; Pro-inflammatoiy cytokines and adipose tissue. Proceedings of Nutrition Society 60; 349-356,2001.

® Cornelius JG, Luttge BG, Peck AB: Antioxidant enzyme activities in IDD-prone and IDD-resistantmice: a comparative study. Free radical Biology and Medicine 14: 409, 1993.

® Craighead IE, McLane MF; Diabetes mellitus: Induction in mice by encephalomyocarditis virus. Science 162; 913, 1968.

® Crisa L, Mordes JP, Rossini A A ; Autoiiraune diabetes mellitus in BB rat. Diabetes Metabolism Reviews; 9, 1992.

e Cryer PE, Polonsky KS: Glucose homeostasis and hypoglycemia.In; Wilson, JD, Foster DN, Kronenberg HM, Larsen PR. (Eds.), Williams Textbook of Endocrinology, 9th ed. W.B. Harcovert Publishers Limited, pp. 939-971, 1998.

» Cushman SW, Wardzala LI; Potential mechanism of insulin action on glucose transport in theisolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. Journal of Biological Chemistry 255:4758-4762, 1980.

0 Czech MP, Corvera S; Signaling mechanisms that regulate glucose transport. Journal of BiologicalChemistry 274: 1865-1868, 1999.

e Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T: Tumor necrosis lactor-alpha in sera of obese patients: fall with weight loss. .lournal of Clinical Endocrinology and Metabolism 83: 2907-2910, 1998.

e Daniel D, Gill RG, Schloot N, Wegmann D: Epitope specificty, cytokine production profile anddiabetogenic activity of insidin specific T-cell clones isolated from NOD mice. European Journal of hnmunoiogy 25: 1056, 1995.

9 Das B, Tandon V, Saha N: Effects of phytochemicals of Flemingia vestita (Fabaceae) on glucose 6-phosphate dehydrogenase and enzymes of gluconeogenesis in cestode {Railliedna echinobothrida). Comparative Biochemistry and Physiology Part C 139: 141-146, 2004.

9 de Courten M, Bennett PH, Tiiomiiehto J, Zimmet P: In International Textbook of Diabetes Mellitus2nd edn (eds Alberti KGMM, Zimmet P, DeFronzo RA, Keen H) Wiley, Chichester 143-170, 1997.

9 de Murcia D: Structure and function of poly (ADP-ribose) polymerase. Molecular and CellularBiochemistry 138: 15-24, 1994.

9 de Souza V, Laurylene C, Sampaio MCC, Sampaio PC, Higino JS: Use of Puniea granatuin as anantifiingal agent against candidosis associated witli denture stoinatitis. Mycoses 46(5-6): 192-196,2003.

e Debelea D, Hanson RL, Bennet PH, Roumain J, Knowler WC, Pettitt DJ: Increasing prevalence oftype II diabetes in American Indian children. Diabetologia 41: 904, 1998.

a DeFronzo RA, Ferrannini E: Insulin resistance; a multifaceted syndrome responsible for NIDDM,obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14: 173, 1991.

6 Delaunay F, Khan A, Cintra A, Davani B, Ling ZC, Andersson A: Pancreatic beta cells are importanttargets for the diabetogenic effects of glucocorticoids. Journal of Clinical Investigation 100; 2094- 2098,1997.

» de-Souza VLC, Sampaio MCC, Sampaio FC, Higino JS; Use of Punica gmnatwn as an antifiangalagent against candidosis associated with denture stomatitis. Mycoses 46(5-6): 192-196,2003.

e Dey BR, Furlanetto RW, Nissley P: Suppressor of cytoldne signaling (S0CS)-3 protein interacts withthe insulin-like growth factor-I receptor. Biochemical and Biophysical Research Commumcations 278: 38-43, 2000.

® DiCosmo BF, Picarella D, Flavel RA: Local production of human IL-6 promotes insulitis but retardsthe onset insulin-dependant diabetes mellitus in non-obese diabetic mice. International Immunology 6: 1829, 1994.

o Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW: Effects of free tatty acids onglucose transport and IRS-l~associated piiospliatidylinositol 3-kinase activity. Journal of ClinicalInvestigatioa 103; 253-9, 1999.

* Durringtoii PN; Diabetes, hypertension and hyperlipidaemia. Postgraduate Medical Journal 69 (])• S18-S29, 1993.

® Eisenbarth GS: Type I diabetes mellitus, A chronic autoininrune disease. New Eni?land Journal of ivledicine 314: 1360, 1986.

9 Eisenberth GS, Gianani R, Yu L: Dual parameter for tlie prediction of type 1 diabetes mellitus. Proceedings of Association of American Physicians 110: 226, 1998.

8 Elchebly M, Payettte P, Miehaliszyn E; increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-IB gene. Science 283: 1544, 1999.

» EI-Fiky FK., Abou-Karam MA, Afify A: Effect of Luffa aeg)>ptiaca (seeds) and Carisa cdulis(leaves) extracts on blood glucoselevel of normal and streptozotocin diabetic rats. Journal ofEthnopharmacology 60; 43-47, 1996.

6 El-Haschimi K, Lehnert FI: Leptin resistance - or why leptin fails to work in obesity Experimentaland Clinical Endocrinology and Diabetes i l l : 2-7, 2003.

® Eisner M, Guldbakke B, tiedge M, Miinday R, Lenzen S: Relative Lnportance of transport and alkylation for pancreatic beta-cell toxicity o f streptozotocin. Diabetologia 43: 1528-1533 2000

® Esmaillzadeh A, Tahbaz F, Gaieni I, Alavi-Majd H , Azadbakht L: Cholesterol-lowering effect ofconcentrated pomegranate juice consumption in typfe 11 diabetic patients with liyperlipidemia.International Journal for Vitamin and Nutrition Research 76(3): 147-51, 2006.

® Etgen GJ, Valasek KM, Broderick CL, Miller AR: In Vivo Adenoviral Delivery of Recombinant Human Protein Kinase C Z Stimulates Glucose Transport Activity in Rat Skeletal Muscle Journal of Biological Chemistry274: 22I39-22I42, 1999,

• Fain J, Scow R, Chemick S: EtTects of glucocorticoids on metabolism of adipose tissue in vitro. Journal of Biological Chemistry 238: 54-58, 1963.

« Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD: Role of melanocortinergic neurons in feeding and tlie agouti obesity syndrome. Nature 385:165-168,1997.

® Fantin VR, Wang Q, Lienhard GE, Keller SR: American Jonnial of Physiology Endocrinoloey and Metabohsm 278: E 127,2000. ^

® Fantus IG, Tsiani B: Multifunctional actions of vanadium compounds on insulin signaling pathways- evidence for preferential enhancement of metabolic versus mitogenic effects. Molecular and Cellular Biochemistry 182: 109, 1998.

. Fasshauer M, Klein J, Neumann S, Eszliager M, Paschke R; Tumor necrosis factor alpha is a negative regiilator of resistin gene expression and secretion b adipocytes. Biochemical andBiophysical Research Communicahons 288: 1027-1031, 2001.

« Fasshauer M, Paschke R: Regulation of adipocytokines and insulin resistance, Diabetologia 46; 1594-1603, 2003.

9 Fehmann HC, Goke R, Goke B: Cell and molecular biology of the incretin hormones glucagon- likepeptide-I and glucose-dependent insulin releasing polypeptide. Endocrine Reviews 16: 390-410, 1995.

® Felber JP, Ferrannini E, Golay A, Meyer HU, Theibaud D, Curchod B; Roie of lipid oxidation inpathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36: 1341-1350, 1987.

9 Felix D, Frangi U: Di methoxy aporphine as an antagonist of chemical excitation. NeuroscienceLetters 4(6): 347-350, 1977.

B Flamez D, Gilon P, Moens K, Van Breusegem A, Delnieire D, Scrocchi LA, Henquin JC, DruckerDJ, Schuit F: Altered cAMP and Ca2̂ * signaling in mouse pancreatic islets with GLP-1 receptor null phenotype. Diabetes 48: 1979-1986, 1999.

9 Flamez D, Van Breuseghem A, Scrocchi LA, Quartier E, Pipeleers D, Drucker DJ, Schuit F: Mousepancreatic p-cells exhibit presei-ved glucose competence after disruption of the glucagon-like peptide1 receptor gene. Diabetes 47: 646-652, 1998.

e Foulis AK, Frances ND, Farquharson MA, Boylston A: Massive synchronous B cell necrosis causingtype I diabetes: a uniquehistopathological case report. Diabetologia 31: 46, 1988.

» French MB, Allison J, Cram DS: Transgenic expression of mouse proinsulin II prevents diabetes innonobese diabetic mice. Diabetes 46: 34, 1997 (erratum appeared in 46 (5): 924, 1997.

® Frevert EU, Bjorbak C, Venable CL, Keller SR, Kahn BE : Targeting of Constitutively ActivePhosphoinositide 3-Kinase to GLUT4-containing Vesicles in 3T3-L1 Adipocytes. Journal of Biological Chemistry 273: 25480-25487, 1998.

» Friedewald WT, Levy RI, Fredrickson DS: Estimation of low-density lipoprotein cholesterol inplasma, wi thout use of the preparative centriilige. Clinical Chemistry 18: 499-502, 1972.

® Fuhrman B, Volkova N, Aviram M: Pomegranate juice inhibits oxidized LDL uptake and cholesterolbiosynthesis in macrophages. Journal of Nutritional Biochemistry 16(9): 570-576, 2005.

® Fimihashi M, lira N, Higashiura K, Murakami H, Tanaka M, Moniwa N, Yoshida D, Shimamoto K:Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. HyiDertension 42: 76-81, 2003.

® Gale EAM: The discovery of type 1 diabetes. Diabetes 50: 217, 2001.

9 Gao, Xichen. (Peop. Rep. China). A traditional Chinese medicine for regulating blood lipid to treatcardiovascular and cerebrovascular diseases, and its preparation. Patent no CN 1565606; Kind A; Date 2005-01-19; Patent written in Chinese 2005.

• Garfinkel AS, Nilsso-Ehle P, Schotz MC: Regulation of lipoprotein lipase; Induction by insulin,Biochimica Biophysica Acta 424: 264-273, 1976.

® Garvey W f, Oletsky JM and Marshall S: Insulin induces progi'cssive insulin resistance in cultured rat adipocytes. Sequential effects at receptor and multiple postreceptor sites. Diabetes 35: 258-267, 1986.

e Garvey WT, Olefsky JM, Matthaei S, Marshall S: Glucose and insulin co-regulate the glucosetransport system in primary cultured adipocytes. A new mechanism of insulin resistance. Journal of Biological Chemistry 262; 189-197, 1987.

0 Geng L, Solimena M, Flavell RA; Widespread expression of an autoantigen GAD65 transgene doesnot tolerize non-obese diabetic mice and can exacerbate disease. Proceedings of National Academy ofScience USA 95; 10055-10060, 1998.

9 Gerich .IE: Glucose counterregulation and its impact on diabetes mellitus. Diabetes 37: 1608-1617,1988.

e Ghosh S, Suryawanshi SA: Effect of Vinca rosea extracts in treatment of alloxan diabetes in male albino rats. Indian Journal of Experimental Biology 39: 748-759, 2001.

« Gibbs EM, Stock JI>, McCoid SC: Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). Journal of Clinical Investigation 95; 1512-1518,1995.

® Gilman AG, Rail TW, Nies AS, Tayer P: In Goodman'and Gilman’s The Pharmacological Basis of Therapeutics, lO"' edition, McGraw-Hill, New Delhi, India, p,13I7-1322,2001.

® Giroix M-H, Portha B, Kergoat M, Bailbe D, Picon L; Glucose insensitivity and amino-acidhypersensitivity of insulin release in rats with non-insulin-dependent diabetes: a study with the perfused pancreas. Diabetes 32:445-451, 1983.

e Giroix M-H, Vesco L, Portha B: Functional and metabolic perturbations in isolated pancreatic isletsfrom the GK rat, a genetic model of noninsulin-dependent diabetes. Endocrinology 132: 815-822, 1993.

e Goldstein BJ; Insulin resistance as the core defect in type 2 diabetes mellitus, American Journal of Cardiology 90; 3-1,0,2002.

e Goldstein BJ; Regulation of insulin action by protein-tyrosine phosphatses. In: LeRoith D, OlefskyJM, Taylor SI, (Eds.) Diabetes Mellitus a fundamental and Clinical Text, Philadelphia, Lippincott- Raven 206, 2000.

e Gould GW, Holman GD, The glucose transporter family; structure, function, and tissue-specificexpression. Biochemical Journal 295, 329-41, 1993.

® Graves PM, Rewers M: The role of entcroviral infections in the development of IDDM: limitations ofcurrent approaches. Diabetes 46: 161,1997.

« Green EZ, Eynon EE, Flavel RA; Local expression of TNFa in neonatal NOD mice promotesdiabetes by enhancing permeation of islet antigens. Immunity 9: 733,1998.

® Grewal IS, Grewal KD, Wong FS; Local expression of transgene encoded TNF alpha in isletsprevents autoimmune diabetes in nonobese diabetic (NOD) tnice by preventing the development of auto-reactive isIet-specific T cells. Journal of Experimental Medicine 184: 1963,1996,

® Grilfen SC, Wang J, German MS; A Genetic Defect in B-Celi Gene Expression SegregatesIndependently From the /?« Locus in the ZDF Rat. Diabetes 50: 63-68, 2001.

e Griffin ME, Marcucci M.I, Cline GW, Bell K, Barucci N, Lee D, Goodyeai- L.1, Kraegen EW, WhiteMF, Shulman Gl: Free fatty acid-induced insulin resistance is associated with activation of protein Icinase C 0 and alterations in the insulin signalling cascade. Diabetes 48; 1270-1274,1999.

s Grover JK, Vats V, Rathi SS: Anti-hyperglycemic effects o f Eugenia jambolana and TinosporacordifoUa in experimental diabetes and their etlects on key metabolic enzymes involved in carbohydrate metabolism. Journal of Ethnopharmacology 73; 461--470, 2000,

6 Grulet H, Duriach V, Hecait AC, Gross A, Leutenegger M: Study of the rate of early glucosedisappearance following insulin iniection, insulin sensitivity index. Diabetes Research in Clinical Practice20; 201-217, 1993.

e Guberski DL, Thomas VA, Shek WR; Induction of type 1 diabetes by Kilham’s rat virus in diabetes-resistant BB/Wor rats. Science 254: 1010, 1991.

® Guillaume-Gentil C, Assimacopoulos-.Ieannet F, Jeanrenaud B; hivolvement of non-esterified fattyacid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats. Diabetologia 36: 899-905, 1993.

® Gulve EA, Ren .IM, Marshall BA, Gao .1, Hansen PA, Holloszy JO: Glucose transport activity inskeletal muscles from ti'ansgenic mice overexpressing GLUT 1. Increased basal transport is associated with a defective response to diverse stimuli that activate GLUT4. Journal of Biological Chemistry 269(28): 18366-18370, 1994.

e Guo S, Deng Q, Xiao J, Xie B, Sun Z: Evalmition of Antioxidant Activity and Preventing DNADamage Effect of Pomegranate Extracts by Chemiluminescence Method. Journal of Agiicultural Food Chemistry [Epub ahead of print]; DOI; 10.1021/jtl363443g; 2007 Mar 24

8 Gupta M, Mazumder UK, Mukhopadhyay RK, Sarkar S; Antisteroidogenic effect of the seed extracto f Neliimbo niicifera in the testis and the ovary of the rat, Indian Journal of Phannaceutical Sciences 58(6): 236-242, 1996.

e Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S: Antidiabetogenic effect of glucagon-likepeptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. New England Journal of Medicine 326: 1316-1322, 1992.

« Haffuer SM, Stern MP, Michell BD, Hazuda HP, Patterson PK: Incidence of type II diabetes mellitusin Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body fat distribution. Diabetes 39: 283, 1990,

® Hakim Mohamed Said: Hamdard Pharmacopoeia of Eastern Medicine. Sri Satgiffu Publications,Delhi, India, pp.211,1997.

® Hales CN, Barker DJ: Type 2 (non-insulin dependant) diabetes mellitus; the thrifty genes hypothesis.Diabetologia 35: 595, 1992.

e Halleux CM, Takaliashi M, Delporte ML, Detiy R, Funahashi T, Matsuzawa Y, liricliard SM:Sexretion of adiponectin and regulation of apMI gene expression in liuraan visceral adipose tissue. Biochemical and Biophysical Research Communications 288: J102-J107, 2001.

e Hanahan D: Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing insulin/simian virus 40 oncogenes. Nature 315: 115,1985.

@ Hannah JS, Verdery RB, Bodkin NL, Hansen EC, Le NA, Howard BV: Changes in lipoproteinconcentrations during the development of noninsulin-dependent diabetes mellitus in obese rhesus monkeys (Macaca miilatta). Journal of Clinical Endocrinology and Metabolism 72; 1067-1072, 1991.

® Hansen PA, Han DH, Marshall BA, Nolte LA, Chen MM, Muecklcr M, Holloszy JO; A High FatDiet Impairs Stimulation of Glucose Transport in Muscle. Functional evaluation of potential mechanisms. Journal of Biological Chemistry 273: 26157-26163, 1998.

® Hansen PA, Han DH, Nolte LA, Chen M, Holloszy JO; DHEA protects against visceral obesity andmuscle insulin resistance in rats fed a high-fat diet. American Journal of Physiology 273: R1704- R1708, 1997.

® Hanson RW, Reshef L: Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression.Annual Review of Biochemistry 66; 581-611, 1997.

9 Harborne JB; In; Phytochemicai Methods. Chapman & Hall, London, pp. 60-66, 1998.

® Hartman HB, Hu X, Tyler I'CX, Dalai CK, Lazar MA: Mechanisms regulating adipocyte expression ofresistin. Journal of Biological Chemistry 277: 19754-19761, 2002.

® Hartman RE, Shah A, Fagan AM, Schwetyc KE, Parsadanian M, Schulman RN, Finn MB, HoltzmanDM: Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiology of Disease 24(3):506-515, 2006.

9 Haskins K, Wegmann D: Diabetogenic T-cell Clones. Diabetes 45; 1299,1996.

® Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S: Mutation of the glucokinasegenes of the fetus results in reduced birth weight. Nature Genetics 19; 268, 1998.

0 Haugen F, Jorgensen A, Drevon CA, Trayhurn P; Inhibition by insulin of resistin gene expression in3T3-L1 adipocytes. FEES Letters 507: 105-108, 2001.

® Hausdorff SF, Fingar DC, Morioka K, Garza LA, Whiteman EL, Summers SA, Birnbaum MJ:Identification of Wortmannin-sensitive Targets in 3T3-L1 Adipocytes. Dissociation of insulin- stimulated glucose uptake and GLUT 4 translocation. Journal of Biological Chemistry 274: 24677- 24684, 1999.

e Hawkins M, Angelov I, Liu R, Barzilai N, Rossetti L: The Tissue Concentration of UDP-iV-acetylglucosamine Modulates the Stimulatory Effect of Insulin on Skeletal Muscle Glucose Uptake. Journal of Biological Chemistry 272: 4889-4895, 1997a.

® Hawkins M, Barzilai N, Chen W, Angelov I, Hu M, Cohen P: Increased hexosamine availabilitysimilarly impairs the action of insulin and IGF-1 on glucose disposal. Diabetes 45: 1734-1743, 1996.

® Hawkins M, Barzilai N, Liu R, Hu M, Chen W, Rossetti L: Role of the Glucosamine Pathway in Fat- induced Insulin Resistance. Journal of Clinical Investigation 99; 2173-21S2, 1997.

e Hediger MA, Coady MJ, Ikeda TS, Wright EM: Expression cloning and cDNA sequencing of the Na+/glueose transporter. Nature 330: 379-381, 1987.

e Hedo JA, Kahn CR, Hayashi M: Biosynthesis and glycosylatioii of insulin receptor. Evidence for a single polypeptide precursor of two major subunits. Joiii-nal of Biological Chemistry 258 (16): 10020, 1983.

e Heffetz D, Zick Y; Receptor aggregation is necessary for activation of the soluble insulin receptor kinase. Journal of Biological Chemistry 261: 889-894, 1986.

e Herold KC, Veyz V, Koons A: CD28/B7 costimulation regulates autoimmune diabetes induced withmultiple low doses of streptozotocin. Journal of Immunology 158: 984, 1997.

e Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Teoman Uysal K, Maeda K, Karin M, HotamisiligilG: A central role for JNK in obesity and insulin resistance. Nature 420: 333-336,2002.

e Holman GD, Kasuga M; From receptor to transporter: insulin signaling to glucose transport. Diabetologia 40: 991-1003, 1997.

« Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha:direct role in obesity-linked insulin resistance. Science 259: 97, 1993.

9 Hotta M, Tashiro F, Ikegami H: pancreatic beta cell-specific suppression of thioredoxin, anantioxidative and antiapoptotic protein prevents autoimmune and streptozotocin-induced diabetes. Journal of Experimental Medicine 188: 1445, 1998.

e Hresko RC, Heimberg H, Chi MMY, Mueckler M: Journal of Biological Chemistry 273: 20658,1998.

® Hu WS, Guo LJ, Feng XL, .Tiang MX: Hemodynamic effects of neferine on normotensive andhypertensive rats. Zhongguo-Yaolixue-Yu-Dulixue-Zazhi 3(1); 43-48, 1989.

® Fluang THW, Peng G, Kota BP, Li GQ, Yamahara J, Roufogalis BD, Li Y; Pomegranate flowerimproves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids. British Journal of Phannacology 145: 767-774,2005a,

® Fluang THW, Peng G, Kota BP, Li GQ, Yamahara J, Roufougalis BD, Li Y: Antidaibetic action ofPimica gmnatim flower extract: Activation of PPAR- and identification of an active component. Toxicology and Applied Pharmacology 207; 160-169, 2005.

® Huang TFIW, Yang Q, Flarada M, Peng G, Li GQ, Yamahara J, Roufogalis BD, Li Y: Pomegranateflower extract diminishes cardiac ;fibrosis in Zucker diabetic fatty rats. Modulation of cardiac Endothelin-1 and Nuclear factor-kappaB pathways. Journal of Cardiovascular Pharmacology 46 (6): 856-862,2005b.

® Hukkeri VI, Kalyani GA, Hatpaki BC, Manvi FV: In viti'o anthelmintic activity of aqueous extract offaiit rind o f Punica gmnatum. Fitoterapia 64(1); 69-70, 1993.

B Hultgrea B, Huang X, Dybal N. Genetic absence of gamraa-interferon delays but does not prevent diabetes in NOD mice. Diabetes 45, 812, 1996,

B Hussein SAM, Barakat HH, Merfort I, Nawwar MAM: Tannins from the leaves o f Pimica granatum. Phytocheinistry 45(4): 819-823,1997.

9 Hwang IS, Ho H, Hoffman BB, Reaven GM: Fructose-induced insulin resistance and hypertension in rats. Hypertension 10: 512-516, 1987.

9 Hyoty H, Hiltunen M, Reunanen A: Decline of mumps antibodies in type (insulin-depeadant) diabeticchildren and a plateau in the rising incidence of ty{)e 1 diabetes after introduction of mumps-measles-rubella vaccine in Finland: Childhood Diabetes in Finland Study Group. Diabetologia 36: 1303, 1993.

» Hyiin SK, Jung YJ, Chung HY, Jung HA, Choi JS: Isorhamaetin glycosides with free radical andONOO-scavenging activities Irom the stamens of Nehimbo micifera. Archives Pharmacal Researcli 29(4):287-292, 2006.

» Ibrahim N, El-Eraqy W. Protein content and amino acid composition o f Nelumho nucifera seeds and its evaluation as hypoglycaemic agent, Egyptian Journal of Pharmaceutical Sciences 37(1-6): 635- 641, 1996.

e limura 0, Shimamoto K, Matsuda K, Masuda A, Taldzawa H, Higashiura K, Miyazaki Y, Hirata A,Ura N, Nakagawa M: Effects of angiotensin receptor antagonist and angiotensin converting enzymeinhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives. American Journal of Hyirertension 8:353-357, 1995.

9 Ikegami H, Makino S, Yamato E: Identification of new susceptibility locus for insulin-dependantdiabetes mellitus by ancestral halotype congenic mapping. Journal of Clinical Investigation 96: 1936, 1995.

e Ishida H, Umiuo T, Tsuji K, Kosuge T: Studies on the antihemorrhagic substances in herbs classifiedas hemostatics in Chinese medicine x. On hemostatic activities of the parched herbs fbr hemostatics. Yakugaku Zasshi i09(3): 179-183,1989,

8 Israili AH; Treatment of Ziabetes (Diabetes with reference to Unani system of Medicine). NagarjunAugust, 1-10, 1977.

<9 Ito M: Development of cosmetic ingredients from Nclumbonaceae plants. Fragrance Journal 33(6):24-27, 2005.

® Itoh N, Hanaftisa T, Miyazaki A: Mononuclear cell infiltration and its relation to expression of majorhistocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependant diabetes mellitus patients. Journal of Clinical Investigation 92: 213, 1993.

® Ivorra MD, Paya M, Villar A: A review of natural products and plants as potential anti-diabetic drugs.Journal ofEthnopharmacology 27: 243-275, 1989.

® Ivorra MD, Paya M, Villar A: Hypoglycemic and insulin release effect of tormentic acid: a newhypoglycemic natural product. Planta Medica 54: 282-286, 1988.

0 Jaeneisch R: Transgenic animals. Science 240: 1468, 1988.

e Jafri MA, Aslam M, .laved K, Singh S: Effect o f Punica gnmatum Linn, (flowers) on lilood glucoselevel in normal and alloxan-induced diabetic rats, .lounial of Ethnopharmacology 70:309-314, 2000.

» Jay RH, Betteridge DJ:In: Textbook of r3iabetes, eds. Piclcup J, Williams G; Blackwell Scientific Publications, Oxford, pp.701, 1991.

9 Jayasooriya AP, Sakono IVI, Yakizaki C, Kawano M, Yamamoto K, Fukuda N: Effects of Moinonlicachamntia powder on serum ghicose levels and various lipid parameters in rats fed with ciiolesterol- ti'ee and cholesterol-enriched diets. Journal of Ethnopharmacology 72: 331-■336, 2000.

® Jenkins DJA, Josse RG: Effect of reduced carbohydrate absorption oo carbohydrate and lipid metabolism. European Journal of Clinical Nutrition 49 (Suppl. 3): s63-s68, 1995.

® Jiang T, Sweeney G, Rudolf MT, Klip A, Traynor-Kaplan A, Tsien RY: Membrane-permeant Estersof Phosphatidyl inositol 3,4,5-Trisphosphale. .fournal of Biological Cliemistry 273: 11017-11024,1998.

® Jolly Cl, Narayanan S, Prabhu SK; Antihypertensive activity of flowers of Pimica gnmatum Linn.(Variety - Gulnar). hidian Journal of Natural Products 16(1): 3-7, 2000.

® Joosten HFP, van der Kroon PHW: Role of the thyroid in the development of the obese-hyperglycemic syndrome in mice (ob ob). Metabolism 23 (5): 425-436, 1974.

a Judd AM, Call GB, Barney M, Mcllmoil CJ, Balls AG, Adams A, Oliveira GK; Possible iunction ofIL-6 and TNF as intraadrcnal factors in tlie regulation of adrenal steroid secretion. Annals of New York Academy of Science 9J 7: 628-637, 2000.

® Jung HA, Kim JE, Chung HY, Choi JS:. Antioxidant principles of Nelwnho nucifera .stamens.Archives of Pharmacal Research (Seoul) 26(4): 279-285, 2003.

® Jung KH, Kim iVIJ, Fla E, Uhm YK, Kim HK, Chung JH, Yim SV: Suppressive Effect of Punicagranatim on the Production of Tumor Necrosis Factor (INF) in BV2 Microglial Cells. Biological

, Phamraceutical Bulletin 29(6):1258-1261, 2006.

0 Juntti-Berggren L, Pigon J, Karpe F, Hamsten A, Gutniak M, Vignati L, Efendic S: Theantidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients. Diabetes Care 19: 1200-1206, 1996.

® Jurjani MI; Zaklieera-Khwarzara-Shahi. Munshi Nawal Kishore, Lucknow, p. 540 (Urdu translation), 1878.

® Kagi D, Ho A, Odeiinatt B: TNF receptor 1-dependant beta cell toxicity as an effector pathway inautoimmune diabetes. Journal of Immunology 162: 4598, 1999.

® Kahn BB, Shulman GI, DeFronzo RA, Cushman SW, Rossetti L; NormaKzation of blood glucose indiabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transpoiler gene expression. Journal of Clinical Investigation 87: 561-570,1991.

s ICanoh Y, Sajan MP, Bandyopadhyay G, Miura A, Standaert LM, Farese RV: Defective activation ofaty[3ical protein kinase c C, and A, by insulin and phospiiatidylinositol-3,4,5-(P04)3 in skeletal muscle of rats following high-fat feeding and streptozotocin-induccd diabetes. Endocrinology 144(3):947“ 954, 2003.

© Kaprio .1, Tuomilehto J, Koshenvuo M: Concordance for type 1 (insulin dependant) and type 2(insulin independent) diabetes niellitus in a population-based cohort of twins in Finland. Diabetologia 35: 1070, 1993.

0 Kar A, Choudhary BK, Bandopadhyay NG: Preliminary studies on the inorganic constituents of someindigenous hypoglycaemic herbs on oral glucose tolerance test. Journal o f Ethnopharmacology 64; 179-184, 1999.

o Karvonen M, Tuomilehto .1, Libnian I: A review of the recent epidemiological data on the worldwideincidencc of type 1 (insulin-dependant) diabetes mellitus. Diabetologia 36: 883, 1993.

e Kasai K, Yoshimura M, Koga T, Arii M, Kawasaki S: Effects of oral administration of ellagic acid-rich pomegranate extract on ultraviolet-induced pigmentation in the human skin. Journal of Nutritional Science and Vitaminology (Tokyo) 52(5):383-388, 2006.

® Kashiwada Y, Aoshima A, Ikeshiro Y, Chen YP, Furukawa H, Itoigawa M, Fujioka 1’, Mihashi K,Cosentino LM, Morris NSL, Lee KH; Anti-HIV benzylisoquinoline alkaloids and flavonoids from the leaves of Nelumbo nudfera, and structure-activity correlations with related alkaloids. Bioorganic and Medicinal Chemistry 13(2): 443-448, 2005.

® Kasim-Karakas SE, Vriend H, Almario R, Chow LC, Goodman MN; Effects of dietary carbohydrateson glucose and lipid metabolism in golden Syrian hamsters. Journal of Laboratory and Clinical Medicine 128:208-213, 1996.

e Katagiri H, Asano T, Ishihara H: Overexpression of the catalytic pi lOalpha of phosphatidylinositol 3-kinase increases glucose transport activity with translocation of glucose transporters in 3T3-L1 adipocytes. .Fournal of Biological Chemistry 271: 16987-16190, 1996.

® Kato M, Miura T, Usami M, Kato A, Kadowaki S: Hypoglycaemic effect of the rhizomes ofophiopogonis tuber in normal and diabetic mice. Biological and Pharmaceutical Bulletin 18: 875-877,1995.

e Katz JD, Wang B, Haskins K: Following a diabetogenic T cell from genesis through pathogenesis.Cell 74: 1089, 1993.

<3 Kaur G, Jabbar Z, Athar M, Alam MS: Piinica grmiatum (pomegranate) flower extract possessespotent antioxidant activity and abrogates Fe-NTA induced hepatotoxicity in mice. Food and Chemical Toxicology 44(7):984-993, 2006.

® Kawaii S, Lansky EP: Differentiation-promoting activity of pomegranate {Piinica granatum) fniitextracts in HL-60 human promyeiocytic leukemia cells. Journal of MedicinalFood 7(1): 13-18,2004.

« Kawano Y, Rincon J, Soler A, Ryder JW, Nolte LA, Zierath JR: Changes in glucose transport andprotein kinase Cbeta(2) in rat skeletal muscle induced by hyperglycaemia. Diabetologia 42: 1071- 1079, 1999.

0 Kayano T, Burant CF, Fukumoto H, Gould GW, Fan YS, Eddy RL, Byers MG, Shows TB, Seirio S, Bell GI: Human facilitative glucoso transporters: isolation, functional characterization, and gene localization of cDNAs encoding an isofonn (GLUT5) expressed in small intestine, kidney, muscle, adipose tissue and an unusual glucose transporter pseudogene-like sequence (GLUT6). Journal of Biological Chemistry 265: 13276-13282, 1990.

® [Cellar RJ, Eisenbarth OS, Jackson RA; Insulin prophylaxis in individuals of high risk of type 1 diabetes. Lancet 341; 927, 1993.

o Kersten S, Desvergne B, Wahli W: Roles of PPARs in health and disease. Nature 405: 421-424,2000.

e Klioursheed M, Miles PD, Gao M, Lee MK, Moossa AR, Olefsky JM: Metabolic effects of troglitazone on tat-induced insulin resistance in the rat. Metabolism 38: 1489-1494, 1995.

® IChan N, Hadi N, Afaq F, Syed DN, Kweon MH, Mukhtar H: Pomegranate fruit extract inhibitsprosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis 28(1): 163-173,2007.

® Kieffer TJ, Habener IF: The glucagons-like peptides. Endocrine Reviews 20 (6); 876-913, 1999.

9 Kieffer TJ, Mchitosh CHS, Pederson RA: Degradation of glucose-dependent insulinotropic polyjjeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase fV. Endocrinology 136: 3585-3596, 1995.

e Kim ND, Mehta R, Yu W, Neeman I, Livney T, Amichay A, Poirier D, Nicholls P, Kirby A, Jiang W,Mansel R, Ramachandran C, Rabi T, Kaplan B, Lansky E: Chemopreventive and adjuvant therapeuticpotential of pomegranate' (Pimica gnmatum) for human breast cancer. ■ Breast Cancer Research , and Treatment 71(3): 203-217, 2002.

6 Kim HK, Park HR, Lee JS, Chirag TS, Chung HY, Chung J: Down-regulation of iNOS and T'NF-alpha expression by kaempferol via NF-kappaB inactivation in aged rat gingival tissues. Biogerontology [Epub ahead of print]; DOI: 10.l007/sl0522-007-9083-9; 2007 (Feb 3).

® Kirtikar, Basu: Illustrated Indian Medicinal Plants. Vol. 6, Sri Satguru publications, Delhi, India,p. 161-166, 2000.

® Kitamura T, Ogawa W, Sakaue LI: Requirement for activation of the serine-threonine kinase Akt(protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Molecular and Cellular Biology 18: 3708-3717,1998.

9 Kohn AD, Barthel A, Kovacina KS: Construction and characterization of a conditionally activeversion of the serine/threonine kinase Akt. Journal of Biological Chemistry 273: I I 937-I I 943, 1998.

» Kohn AD, Kovacina KS, Roth RA: Insulin stimulates the kinase activity of RAC-PK,a pleckstrin homology domain containing ser/thr kinase. EMBO Journal 14: 4288-4295, 1995.

® Kohn AD, Takeuchi F, Roth RA: Akt, a Pleckstrin Homology Domain Containing Kinase, IsActivated Primarily by Pho.sphorylation. Journal of Biological Chemistry 271: 21920,1996.

e Kohno H, Suzuki R, Yasui Y, Hosokawa M, Miyaslvita K, Tanaka T: Pomegranate seed oil rich inconjugated linoienic acid suppresses chemically induced colon carcinojfenesis in rats. Cancer Science 95(6): 481-486, 2004.

® Kolb H, Kroncke KD: IDDM; lesson from low dose streptozotodn model in mice. Diabetes Review 1:116,1993.

e Kolb H: Benign versus destructive insulitis. Diabetes Metabolism Reviews 13: 139, 1997.

a Kraegen EW, James DE, Storlien LH, Burleigh KM, Chisliolm D.F: In vivo insulin resistance inindividual peripheral tissues of the high fat fed rat: assessment by euglycaemic clamp plus deoxyglucose administration. Diabetologia 29: 192-198, 1986.

® Kriska AM, LaPorte RE, Pettitt D.1: The association of physical activity with obesity, fet distributionand glucose intolerance in Pima Indians. Diabetologia 36: S63, 1993.

e Krook A, Roth RA, Jiang XJ, Zierath JR, Wallberg-Henriksson H: Insulin'stimulated Akt kinaseactivity is reduced in skeletal muscle from NIDDM subjects. Diabetes 47: 1281-1286, 1998.

* Kulas DT, Goldstein BJ, Mooney RA: The transraembrane protein tyrosine phosphatase LARmodulates signaling by multiple receptor tyrosine kinases. Journal of Biological Chemistry 217: 748,1996.

s Kullin M et al., K (ATP) channel openers protect rat islets against the toxic effect of streptozotocin.Diabetes 49: 1131-1136,2000.

®. Kulkarni AP, Aradhya SM, Divakar S: Isolation and identification of a radical scavenging antioxidant- punicalagiii from pith and carpellary membrane of pomegranate Iruit Food Chemistry 87(4): 551- 557,2004. ■

0 Kuo YC, Lin YL, Liu CP, Tsai WJ. Herpes simplex virus type 1 propagation in HeLa cellsinterrupted by Nelumbo niicifera. Journal of Biomedical Sciences 12(6):1021-1034,2005.

« Kwak HM, Jeon SY, Sohng BK, Kim JG, Lee JM, Lee KB, Jeong HH, Hur JM, Kang YII, Song KS:Beta-Secretase (BACEl) inhibitors from pomegi'anate (Punica granatiim) husk. Archives of Pharinacal Research 28(12):1328-1332, 2005.

e La B, Molgaard P, Yi Z: Traditional Chinese medicine in treatment of Jiyperlipidaemia. Journal ofEthnopharaiacology 46(2): 125-129, 1995.

® Laitinen T, Vauhkonen IK, Niskanen LK, Hartikainen .IE, Lansimies EA, Uusitupa MI: Powerspectral analysis of heart rate variability duiing hyperinsulinemia in nondiabetic offspring of type 2 diabetes patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes 48: 1295-1299,1999.

® Lammers R, Bossenmaier B, Cool DE: Differential activities of protein tyrosine phosphatase in intactcells. Journal o f Biological Chemistiy 268:22456, 1993.

e Lampeter EF, Klinghammer A, Scherbaum WA: The Deutsche Nicotinamide intervention Study: anattempt to prevent type 1 diabetes DENIS Group. Diabetes 47: 980, 1998.

® Lang CH, Dobrescu C, Bagby GJ: Tumor necrosis factor impairs insulin action on peripheral glucosedisposal and hepatic glucose output. Endocrinology 130: 43, 1992,

B Lansky EP, Hamson G, Froom P, Jiang WG; Pomegranate (Puiuca granatwn) pure chemicals sliowpossible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel(TM). Investigational New Drags 23(2); 121-122, 2005.

a Le Leiy S, Boucher .T, Rey A, Castan-Laurell 1, Krief S, Ferre P: Dccreasod resistin expression in micewith different sensitivities to a high-fat diet. Biochemical and Biophysical Research Communications 289; 564-567, 2001.

e Lebovitz HE, Pasmaotier R; Combination insulinsultbnylurea therapy. Diabetes Care 13: 667-675,1990.

® Lee HK, Choi YM, Noh DO, Suh HJ: Aatioxidant effect of Korean traditional lotus liquor(Yunyupju). International Journal of Food Science andTechnology 40(7): 709-715, 2005.

e Lee MK, Miles PD, Khoursheed M, Geo KM, Moossa AR, Olcfeky JM: Metabolic effects oftroglitazone on fructose-induced insulin resistance in the rat. Diabetes 43: 1435-1439,1994.

® Leturque A, Loizeau M, Vaulont S, Salrninen M, Girard J: Improvement of insulin action in diabetictransgenic mice selectively overexpressing GLUT4 in skeletal muscle. Diabetes 45; 23-27, 1996.

® Li GR, Li XG, Lu FH: EtTects of neferine on transmembrane potential in rabbit sinoatrial nodes andclusters of cultured myocardial cells from neonatal rats. Acta Pharmacologica Sinica 10(4): 328-331, 1989a.

® Li GR, Li XG, Lu FH: Effects of neferine on transmembrane potentials of guinea-pig myocardium.Acta Pharmacologica Sinica 10(5): 406-410, 1989.

o Li GR, Lue FH, Qian JQ: Effects of neferine on physiologic properties and the dose-effect responseof isoprenaliiie and calcium in guinea-pig atria. Yaoxue-Xuebao. 23(4): 241-245, 1988.

® Li GR, Qian .IQ, Lu FH: Effects of neferine on heart electromechanical activity in anesthetized cats.Acta Pharmacologica Sinica 11(2): 158-161, 1990,

® Li GR, Qian JQ, Lu FH: Effects of neferine on isolated rabbit myocardium. Acta PharmacologicaSinica 9(2): 139-142,1988a.

a Li J, Yu X, Pan W, Unger RFI: Gene expression profile of rat adipose tissue at the onset of high-fat-diet obesity, American Journal of Physiology, Endocrinology and Metabolism 282: E1334-E1341, 2002 .

® Li Y and Lazar MA: Differential Gene Regulation by PPARgamma Agonist and ConstitutivelyActive PPARgamma2. Molecular Endocrinology 16: 1040-1048,2002.

® Li Y, Guo C, Yang J, Wei J, Xu J, Cheng S; Evaluation of antioxidant properties of pomegranatepeel extract in comparison with pomegranate pulp extract. Food Chemistry 96(2): 254-260,2006,

s Li Y, Wen S, Kota BP, Peng G, Li GQ, Yamahara J, Roufogalis BD; Piinica granatmn flower extract, a potent a-glucosidase inhibitor, improves postprandial hyperglycaemia in Zucker diabetic fatty rats. Journal of Ethnopharmacology 99: 239-244, 2005.

0 Li, Xuetao. (Peop. Rep. China)."Qifang" blood sugar lowering powder and its preparation. Patent no. CN 1439383; Kind A; Date 2003-09--03 Patent written in Chinese 2003.

e Like AA, Rossini AA: Streptozotocin-induced pancreatic insulitis: New model of diabetes mellitus. Science 193:415, 1976.

e Lirn SS, Jung Y.1, Hyim SK, Lee YS, Choi JS: Rat lens aldose reductase inhibitory constituents of Nelumbo nucifem stamens. Phytotherapy Research 20(10):825-830, 2006.

0 Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S,Kjeldsen SE, Kristiansson K, Lederballe-Pedersen 0, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman J, Snapinn S: Cardiovascular morbidity and mortality in patients with diabetes in the Losartau Intervention For Endpoint reduction in liy]:»ertension study (LIFE): a randomised trial against atenolol. Lancet 359 : 1004-1010, 2002.

e Ling ZQ, Xie BJ, Yang EL: Isolation, characterization, and determination of anti oxidative activity of oligomeric procyanidins from the sccdpod of Nelumbo nudfera Gacrtn. Jouma! of Agricultural and Food Chemistry 53(7): 2441-2445, 2005.

s Lithell HO, McKeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA; Relations of size at birth tonon-insulin dependant diabetes mellitus and insulin concentrations in men aged 50-60 years. British Medical Journal 312: 406, 1996.

® Liu IM, Hsu FL, Chen CF, Cheng JT: Antihyperglycernic action of isoferulic acid in streptozotocin-induced diabetic rats. British .lournal of Phannacology 129:631-636, 2000.

e Liu CP, Tsai WJ, Lin YL, Liao JF, Chen CF, Kuo YC: The extracts from Nelumbo nudfera suppressceil cycle progi-ession, cytokine genes expression, and cell proliferation in human peripheral blood mononuclear cells. Life-Sciences 75(6): 699-716, 2004.

® Liu CP, Tsai WJ, Shen CC, Lin YL, Liao JF, Chen CF, Kuo YC: Inhibition of (S)-armepavine fromNelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice. European Journal of Pharmacology 531(1-3): 270-279, 2006.

® Liu CP, Kuo YC, Shen CC, Wu MH, Liao JF, Lin YL, Chen CF, Tsai WJ: (S)-Armepavine inhibitshuman peripheral blood mononuclear cell activation by regulating Itk and PLC {gamma} activation in a PI-3K-dependcnt manner. Journal of Leukocyte Biology [Epub ahead of print]; DOLIO.I I89/jlb.0106056; 2007 (Feb 6),

® Loren DJ, Seeram NP, Schiilman RN, Holtzman DM: Maternal dietary supplementation withpomegranate juice is neuroprotective in an animal model of neonatal hypoxic-ischemic brain injury. Pediatric Research 57(6): 858-864, 2005.

® Lowry OH, Rosenburg NJ, Fair Al: Protein measurement with Folin’s phenol reagent. Journal ofBiological Chemistry 193: 265,1951.

® Lu M, Wheeler MB, Leng XH, Boyd III AE: The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polyiJeptide and glucagon-like peptide f (7-37), Endocrinology 132, 94- 100, 1993,

fs Lundbaek K: Intravenous glucose tolerance a tool in definition and diagnoses of diabetes mellitus. British Medical Journal 1; 1507-1513, 1962,

s Maegawa H, Ide R, Hasegawa M; Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein tyrosine phosphatase activities. Journal of Biological Chemistry 270: 7724, 1995,

e Majoosi AIA: Kamilussanah. Munshi Nawal Kisliore, Lucknow, p. 145 (Urdu translation by Kantoori), 1889.

e Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H; Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 102(41); 14813-14818, 2005.

® Malik A, Mukhtar H; Prostate cancer prevention through pomegranate fruit. Cell Cycle 5(4):37l-373,2006.

e Manco M, Calvani M, Mongrone G: Effects of dietary fetty acids on insulin sensitivity and secretion. Diabetes, Obesity and Metabolism 6: 402-413, 2004.

® Mantzoros CS; The role of leptiii in human obesity and disease; a review of current evidence. Annalsof Internal Medicine 130; 651-657, 1999.

8 Markovic TP, Jenkins AB, Campbell LV, Furler SM, Kraegen EW, Chisholm DJ: Thje determinantsof glycemic responses to diet restriction and weight loss in obesity and NIDDM. Diabetes care 21; 687-694, 1998.

® Maries RJ, Farnsworth NR: Antidiabetic plants and their activc constituents. Phytomedicine 2; 133-189, 1995.

e Marshall S, Bacote V, Traxinger RR: Discovery of a metabolic pathway mediating glucose-induceddesensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. Journal of Biological Chemistry 266; 4706-4712, 1991.

8 Martin SS, Haruta T, Morris AJ, Klippel A, Williams LT, Olel^ky JM; ActivatedPhosphatidylinositol 3-Kinase Is Sufficient to Mediate Actin Rearrangement and GLUT4 Translocation in 3T3-L1 Adipocj^es. Jourital of Biological Chemistry 271; 17605-17608, 1996.

e Martinez JA, Margareto J, Marti A, Milagro FI, Larrarte E, Moreno Aliaga MJ; Resistinoverexpression is induced by a beta3 adrenergic agonist in diet-related overweightness. Journal of Physiology and Biochemistry 57; 287-288, 2001.

® Mam I, Ohnishi J, Yamaguchi S, Oda Y, Kakehi K, Ohta Y; An estrogen-like activity in pomegranatejuice. Nippon Shokuhin Kagaku Kogaku Kaishi 48(2): 146-149, 2001.

® Mattliews PD, Haas GJ; Antimicrobial activity of some edible plants: Lotus {Neliimbo micifera),coffee, and others. Journal of Food Protection 56(1); 66-68, 1993.

e Mayer W, Goemer A, Aiidrae K: Punicalagin and punicalin 2 tannins from pomegranate peel. Justus Liebigs Annalen derChemie (11-12): 1976-1986, 1977.

o Mazumder UK, Gupta M, Praiiiatiik G, Mukhopadhyay RR, Sarkav S; Antifevtility activiVy of seed of nelumbo-nucifera in mice. Indian Journal of Experimental Biology 30(6): 533-534, 1992.

® McClain DA, Crook ED: Hexosamines and insulin resistance. Diabetes 45: 1003-1009, 1996.

a McFarlane SI, Kumar A, Sowers JR: Mechanisms by which angiotensin-converting enzymeinliibitors prevent diabetes and cardiovascular disease. American Journal of Cardiology 91: 30H- 37H, 2003.

0 McGuire MC, Fields RM, Nyomba BL: Abnormal regulation of protein tyrosine pliosphataseactivities in skeletal muscle of insulin-resistant humans. Diabetes 40: 939, 1991.

® Miles P, Higo K, Romeo 0, Lee M, Rafaat K, Olefsky J: Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance. Diabetes 47: 395-400, 1998.

8 Miles PD, Romeo OM, Higo K, Cohen A, Rafaat K, Olefsky JM: TNF-alplia-induced insulinresistance in vivo and its prevention by troglitazone. Diabetes 46: 1678-1683, 1997.

e Miura T, Kato A: The difference in hypoglycaemic action between Polygonati rhizoma andPolygonati officinalis rhizoma. Biological and Pharmaceutical Bulletin 18: 1605-1606, 1995.

® MJ, Sharma RP, Sale GJ. Site-specific dephosphorylation and deactivation of human insulin receptortyrosine kinase by particulate and soluble phosphotyrosyl protein phosphatases. Biochemical Journal 275,413,1991.

® Moller DE: New targets for type 2 diabetes and metabolic syndrome. Nature 414: 821-827, 2001.

® Mommsen TP, Walsh PJ, Moon TW: Gluconeogenesis in hepatocytes and kidney of atlantic salmon.Molecular Physiology 8: 89-100, 1985.

® Mooney RA, Senn J, Cameron S, Inamdar N, Boivin LM, Shang Y, Furlanetto RW; Suppressors ofcytokine signaling-1 and -6 associate with and inhibit the insulin receptor: a potential mechanism for cytokinemediated insulin resistance. Journal of Biological Chemistry 276: 25889-25893,2001.

0 Mordes JP, Greiner DL, Rossini AA : Animal models of autoimmune diabetes melHtus. In: DiabetesMellitus, A Fundamental and Clinical Text, LeRoith D, Taylor SI, .Olefsky JM; (eds.) 2"‘' Edition, Lippincott Williams & Wilkins, Philadelphia, USA, pp. 430-441, 2000.

e Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Rosato FE, Goldstein BJ:Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. Journal of Clinical Endocrinology and Metabolism 87: 5662-5667, 2002.

* Moyers JS, Bilan PJ, Reynet C, Kahn CR: Overexpression of Rad inhibits glucose uptake in culturedmuscle and fat cells. Journal of Biological Chemistry 271: 23111-23116, 1996.

8 Mueckler M, Caruso C, Baldwin SA, Panico M, lileiicli 1, Morris HR, Allard WJ, Lienhard GE,Lodish HF: Sequence and structure of a human glucose transporter. Science 229: 941-945, 1985.

® Mukherjee PK, Das J, Balasubramanian R, Saha K, Pal M, Saha BP; Antidiarrlioeal evaluation ofNelumbo nucifera rhizome extract. Indian Journal of Pharmacology 27(4): 262-264, 1995.

® Mukherjee PK, Daa J, Saha K, Girl SN, Pal M, Saha BP: Antipyretic activity of Nelumbo nuciferarhizome extract. Indian Journal of Experimental Biology 34(3): 275-276, 1996a.

0 Muldierjee PK, Saha K, Balasubramanian R, Pal M, Saha BP: Studies on psychopharmacologicaleffects oiNelumbo nucifera Gaertn. rhizome extract. Journal ofEthnopannacology 54: 63-67, 1996.

® Muklierjee PK, Saha K, Das J, Pal M, Saha BP: Studies on the anti-inflammatory activity of rhizomeso f Nelumbo nucifera. Planta Medica 63(4): 367-369, 1997a.

e Mukherjee PK, Saha K, Pal M, Saha BP: Effect of Nelumbo nucifera rhizome extract on blood sugarlevel in rats. Journal of Ethnophannacology 58: 207- 213, 1997.

e Murray I, Sniderman AD, Havel PJ, Cianflone K: Acylation stimulating protein (ASP) deficiencyalters postprandial and adipose tissue metabolism in male mice. Journal of Biological Chemistry 274: 36219-36225, 1999.

® Murthy KNC, Jayaprakasha GK, Singh RP: Studies on antioxidant activity of pomegranate {Punicagranatum) peel extract using in vivo models. Journal of Agricultural and Food Chemistry 50(17): 4791-4795, 2002.

® Murthy KNC, Vittal RK, Veigas JM, Murthy UD: Study on wound healing activity of Punicagranatum peel. Journal of Medicinal Food 7(2): 256-259, 2004.

® Nagaev I, Smith U: Insulin resistance and ty[)e 2diabetes are not related to resistin expression inhuman fet cells or skeletal muscle. Biochemical and Biophysical Research Communications 2S5: 561-564, 2001.

® NDDG (National Diabetes Data Group). Classification and diagnosis of diabetes meliltus and othertypes of glucose intolerance. Diabetes 28: 1039, 1979.

e Nauck M, Stockmann F, Ebert R, Creutzfeldt W: Reduced incretin effect in tyj^e 2 (non-insulin-dependent) diabetes. Diabetologia 29: 46-52, 1986.

® Nauck MA, Kleine N, 0rskov C, Holst JJ, Willms B, Creutzfeldt W: Normalization of fastinghyperglycemia by exogenous glucagon-like peptide 1(7-36) in type 2 (non-insulin-dependent) diabetes patients. Diabetologia 36: 741-744, 1993.

0 Nauck MA, Weber I, Bach I, Richter S, 0rskov C, Holst JJ, Schmiegel W: Normalization of fastingglycaemia by intravenous GLP-1 ([7—36 amide] or [7—37]) in type 2 diabetic patients Diabetes Medicine 15: 937-945, 1998.

e Nawwar MAM, Hussein SAM, Merfort I: Leaf phenolics of Punica granatum. Phytochemistry37(4): 1175-1177,1994.

© Navvwar MAM, Hussein SAM, Merfort I: NMR spectral analysis of polyphenols from Piinica gnmatim . Phytochemistry 36(3): 793-798, 1994a.

e Negi PS, Jayaprakasha GK, Jena BS: Antioxidant and antimutagenic activities of pomegranate peel extracts. Food Chemistry 80(3): 393-397, 2003.

e Negi PS, Jayaprakasha GK: Antioxidant and antibacterial activities of P unka granatum peel extracts. Journal of Food Science 68(4): 1473-1477, 2003.

® Nikkila F,A, Huttuneii JK, Ehnholm C: Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Diabetes 26: 11-21, 1977.

e Noda Y, Kaneyuki T, Mori A, Packer L: Antioxidant activities of pomegranate liiiit extract and its anthocyanidins: Delphioidin, cyanidin, and pelargonidin Journal of Agricultural and Food Chemistry 50(1): 166-171,2002.

e Noor FI, Hammonds P, Sutton R, Ashcroft SJFI: The hypoglycaemic and insulinotropic activity of Tinospora crispa: Studie.s with hmnan and rat islets and HIT-T15 B cells. Diabetologia 32: 354-359,1989.

e Norris JM, Beaty B, Klingensmith G: Lack of association between early exposure to cow’s milk protein and p-cell autOimmunity: Diabetes autoimmunity study in the young (DAISY). Journal of American Medical Association 276: 609, 1996.

9 Nyholm B, Walker M, Gravholt CH, Shearing PA, Sturis J, Alberti KG: Twenty four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations. Diabetologia 42: 1314-1323, 1999.

® O’Dea K: Westernisation, insulin resistance and diabetes in Australian Aborigines. Medical Journal of Australia 155: 258-264,1991.

e Ogawa y , Masuzaki H, Isse N, Okazaki T, Mori T, Nakao K: Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fotty (fa/fa) rats. Journal of Clinical Investigation 96; 1647-1652, 1995.

e Okada T, Kawano Y, Sakakibara T, Hazeki 0 , Ui M: Essential role of phospliatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. Journal ofBiological Chemistry 269: 3568, 1994.

® Okamato H: Regulation of proinsulion synthesis in pancreatic islets and a new aspect to insulin dependant diabetes. Molecular and Cellular Biochemistry 37: 43-61, 1981.

® Oldstone MBA: Prevention of type 1 diabetes in nonobese diabetes mice by virus infection. Science 239: 500, 1988.

a Oliver B, Daniel B, Portha B: Relation of insulin deficiency to impaired insulin action in NIDDM adult rat given streptozotocin as neonates. Diabetes 38: 610-617, 1989.

® Oliver WR, Jr Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL, Lewis MC, Winegar DA,Sznaidman ML, Lambert MH, Xu HE, Stembach DD, Kliewer S A, Hansen BC, Willson TM: Proceedings of National Academy of Sciences USA 98; 5306, 2001.

® Onishi E, Yamada K, Yamada T, Kaji K, Inoiie H, Seyama Y, Yamashita S: Comparative effects ofcrude drugs on serum lipids. Chemical and Pharmaceutical Bulletin 32(2): 646-650, 1984.

® Ono Y, Hattori E, Fukaya Y, Lnai S, Ohizumi Y: Anti-obesity effect of Nelumbo nucifera leavesextract in mice and rats. Journal of Ethnophamiacology 30; 106(2):238-244, 2006.

® 0rskov C: Glucagon-likc peptide-1, a new hormone of the entero-insular axis Diabetologia 35: 701-711, 1992.

0 Pagano G, Cavallo-Perin P, Cassader M, Bruno A, Ozzello A, Ma.?ciola P: An in vivo and in vitrostudy of the mechanism of prednisone-induced insulin resistance in healthy subjects, .loiirnal of Clinical Investigation 72: 1814-1820, 1983.

a Paik SG, Fleischer N, Schin S. Insulin-dependant diabetes mellitus induced by subdiabetogenic dosesstreptozotocin: obligatory role of cell mediated autoimmune processes. Proceedings of National Academy of Science USA, 77, 6129,1980.

s Pak CY, Cha CY, Rajotte RV: Human pancreatic islet cell-specific 38 kD autoanigen identified bycytomegalovirus-induced monoclonal islet cell autoantibody. Diabetologia 33: 569,1990.

® Pak CY, Eiin HM, McArthur RG, Yoon JW: Association of cytomegalovirus infection withautoimmune type 1 diabetes. Lancet 2: 1, 1988.

® Pamir N, Lynn FC, Buchan AM, Ehses J, Hinke SA, Pospisilik JA, Miyawaki K, Yamada Y, SeinoY, McIntosh CH, Pederson RA: Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes' in the enteroinsular axis. American Journal of ’Physiology, Endocrinology and Metabolism 284: E931-E939, 2003.

® Pan XR, Li GW, Hu YH: Elfects of exercise and dier in preventing NIDDM in people with impairedglucose tolerance: the Da Qing IGT and Diabetes study. Diabetes Care 20: 537, 1997.

® Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Dogardus C: Skeletal muscle triglyceridelevels are inversely related to insulin action. Diabetes 46: 983-8, 1997a.

® Park SH, Ko SK, Chung SPL Euonymus alatus prevents the hyperglycemia and hyi^erlipidemiainduced by high-fat diet in ICR mice. Journal Etlmopharmacology I02(3):326-35, 2005.

® Pederson RA, White LIA, Schlenzig D, Pauly RP, McIntosh CH, Demuth HU: Improved glucosetolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolicHde. Diabetes 47: 1253-1258, 1998.

© Pellegrino M, Christophe B, Rene G, Michele R, Michele M, Dominique II, Michela N, Gerard R.Experimental NIDDM: Development of a New Model in Adult Rats Administered Streptozotocin and Nicotinamide. Diabetes 47(2): 224-229, 1998.

e Pessin JE, Ihurmond DC, Elmendort JS, Coker KJ, Okada S: Molecular basis of insiilin-stimulated GLUT4 vesicle trafficking. Location! Location! Location! Journal of Biological Chemistry 274: 2593-2596, 1999.

9 Pettitt DJ, Aleck ICA, Baird HR, Camher MJ, Bennet PH, Knowler WC; Congenital susceptibility to NIDDM; the role of intrauterine environment. Diabetes 37: 622,1988,

s Pettitt DJ, Forman MR, Hanson RL, Knowler LC, Bennet PH: Breastfeeding and incidence of non­insulin dependant diabetes mellitus in Pima Indians. Lancet 350: 166, 1997.

a Pfeffer SR: Transport-vesicle targeting: tethers before SNAREs. Nature Cell Biology 1(1): 17-22,1999.

• Pickup JC, Chusney GD, Thomas SM, Burt D: Plasma interleukin-6, lumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Science 67:291-300, 2000.

® Pilkis SJ, El-Maghrabi: Hormonal regulation of hepatic gluconeogenesis and glycolysis. Annual Review of Biochemistry 57: 755-783, 1988.

® Pillai NR; Anti-diarrhoeal activity of Punica gmnatum in experimental animals. International Journal of Pharmacognosy 30(3): 201-204,1992.

e Polonsky KS, Given BD, Hirsch I, Tilil H, Shaipiro BT, Beebe C: Abnormal patterns of insulinsecretion in non-insulin dependent diabetes mellitus. New England Journal of Medicine 318: 1231- 1239, 1988.

a Portha B, Levancher AE, Picolon L, Rosselin G: Diabetogenic effect of streptozotocin in the ratduring the prenatal period. Diabetes 23: 883-895, 1979a.

® Portha B, Picolon L, Rosselin G: Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia 17: 371-377, 1979.

» Portha B, Serradas P, Bailbe D, Suzuki K, Goto Y, Giroix MH: Beta-cell insensitivity to glucose inthe GK rat, a spontaneous nonobese model for type 2 diabetes. Diabetes 40: 486-491, 1991.

® Poulsen P, Kyvik KO, Vaag A, Beck-Nielson H: Heritability of type II (non-insulin dependant)diabetes mellitus and abnormal glucose tolerance: a population based twin study. Daibetologia 42: 139, 1999.

8 Poyrazoglu E, Gokmen V, Artik N: Organic acids and phenolic compounds in pomegranates (Punica granatum L.) grown in Turkey Journal of Food Composition and Analysis 15(5): 557-575, 2002.

9 Prakash AO: Potentialities of some indigenous plants for antifertility activity. International Journal of Caide Drug Research 24(1): 19-24, 1986.

e Prasanth D, Padmaja R, Samiulla DS: Effect of certain plant extracts on alpha-amylase activity.Fitoterapia 72(2): 179-181,2001.

® Prince PSM, Menon VP, Pari L: Hypoglycemic activity of Syzigiim cumini seeds: effect on lipidperoxidation in alloxan diabetic rats. Journal of Ethnopharmacology 61: 1-7,1998.

® Pugliese A, Gianani R, Moromisato R: HLA-DQB 1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first degree relatives of patients with IDDM. Diabetes 44: 608, 1995.

a Qi D, Pulinilkimnil T, An D, Ghosh S, Abrahani A, Pospisilik JA, Brownsey R, Wambolt R, Allard M, Brian Rodrigues B: Single-dose dexamethasone induces whoie-body insulin resistance and alters both cardiac fatty acid and carbohydrate metabolism. Diabetes 53: 1790-1797, 2004.

0 Qian-Jia-Qiiig: Cardiovascular pharmacological effects of bisbenzylisoquinoHne alkaloid derivatives. Acta Pharmacologica Sinica 23(12): 1086-1092, 2002.

e Rabin DU, Pleasic SM, Palmer-crocker R, Shapiro JA: Cloning and expression of IDDM-specific human autoantigens. Diabetes 41:183, 1992.

9 Rabiiiovitch A: Iinmunoregulatory and cytokine imbalances in the pathogenesis of IDDM:therapeutic intervention by immunostimiilation? Diabetes 43: 613, 1994.

® Rabinovitch A, Saurez-Pinzon W, El-Sheik A, Sorenson 0, Povvere RF, Cytotoxic gene expression in pancreatic islet infiltrating leukocytes of BE rats: expression of Thl cytokines correlates with beta­cell destructive insulitis and IDDiVI. Diabetes 45 (6), 749,1996.

® Rachman J, Barrow BA, Levy JC, Turner RC: Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM. Diabetologia 40: 205-211,1997,

® Rai S, Wahile A, Mukherjee K, Saha BP, Mukherjee PK. Antioxidant activity of Nelumbo nucifera (sacred lotus) seeds. .Journal of Etlmopharmacology 104{3):322-327,2006.

® Rajii J, Gupta D, Rao AR: Trigonellafoemim graecim (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Molecular and C^ellular Biochemistry 224:45-51,2001.

e Rakietan N, Rakietan ML, Nadkarni MV: Studies on diabetogenic action of streptozotocin. Cancer Chemotherapy 29: 91-98, 1963.

o Rakietan N: Pancreatic islet tumours produced by the combined action of streptozotocin andnicotinamide. Proceedings of Society of Experimental Biology and Medicine 137: 280-283, 1971.

® Ramachandran A, Snehalatha C, Latha E, Vijay V, Viswanathan M: Rising prevalence of NIDDM in an urban population in India. Diabetologia 40: 232-237,1997.

® Randle P, Garland P, Hales C, Newsholme E: The glucose fatty acid cycle: its role in insulinsensitivity and tlie metabolic disturbances of diabetes mellitus. Lancet 1: 785-789, 1963.

e Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DE, Johnson 0 : Tissue specific dysregulation of cortisol metabolism in human obesity. Journal of Clinical Endocrinology and Metabolism 86(3): 1418-1421,2001.

8 Rathi SS, Grover JK, Vats V: Anti-hyperglycemic effects of Momordica chamntia and Miicuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism. Phytotherapy Research 16: 236-243,2002.

® Ray field E, Kelly K, Y oon JW; Rubella virus-induced diabetes in hamsters. Diabetes 35: 1276, 1986.

e Rea S, James DE: Moving GLUT4: the biogenesis and trafficking of GLUT4 storage vesicles Diabetes 46:1667-77,1997.

9 Ren JM, Li PM, Ziiang RW; Transgenic mice deficient in the LAR protein tyrosine phosphatase exhibit profound defects in glucose homeostasis. Diabetes 47: 493, 1998.

e Ribon V, Printen JA, Hoffman NG, Kay BK, Saltiel AR: A novel, multifunctional c-Cbl bindinj. protein in insulin receptor signaling in 3T3-L1 adipocytes. Molecular and Cellular Biology 18; 872- 879, 1998.

e Ribon V, Saltiel AR: Insulin stimulates tyrosine phosphorylation of the proto-oncogene product of c- Cbl in 3T3-L1 adipocytes. Biochemical Journal 324: 839-846,1997.

® Riddick F, Reisler D, Kipnis D: The sugar transport system in striated muscle. Diabetes 11: 171-178, 1962.

® Rizza RA, Cryer PE, Haymond MW, Gerich JE: Adrenergic mechanisms tor the effects of epinephrine on glucose production and clearance in man. Journal of Clinical Investigation 65: 682- 689, 1980.

o Roden M, Price TB, Persegliin G, Petersen KF, Rothman DL, Cline GW: Mechanism of free fatty acid-induced insulin resistance in humans. Journal of Clinical Investigation 97: 2859-2865, 1996.

o Rodrigues B, Goyal RK, McNeill JH: Effects of hydralazine on STZ-induced diabetic rats-prevention of hyperlipidaemia and improvement in cardiac function. Journal of Pharmacology and Experimental Therapeudcs 237: 299-307, 1986.

® Rooney DP, Neely RD, Cullen C, Ennis CN, Sheridan B, Atkinson AB: The effect o f cortisol on giucose/glucose-6-phosphate cycle activity and insulin action. Journal of Clinical Endocrinology and Metabolism 77(5): 1180-1183, 1993.

® Rosen OM: After insulin binds. Science 237: (4821), 1452-1458, 1987.

o Rosenbaum M, Nicolson M, Hirsch J, Murphy E, Chu F, Leibel RL: Effects of weight change on plasma leptin concentrations and energy expenditure. Journal of Clinical Endocrinology and Metabolism 82: 3647-3654, 1997.

» Ross RG, Selvasubramaniaii S, Jayasundar S: Immunomodulatory activity of Punica granatum in rabbits: A preliminary study. Joumal-of-Ethnopharmacology 78(1): 85-87, 2001.

e Ross RG, Selvasubramanian S, Samuel JJ: Effect of Punica granatum on dexamethasone induced immunosuppression in rabbits, Indian Journal of Animal Sciences 74(2): 139-142, 2004a.

e Ross SA, Gulve EA, Wang M: Chemistry and biochemistry of type 2 diabetes. Chemical Reviews 104: 1255-1282, 2004.

• Rossetti L, Giaccaii A, DeFronzo RA: Glucose toxicity. Diabetes Care 13: 610-630,1990.

0 Rossetti L, Hawkins M, Chen W, Gindi J, Barzilai N: In vivo glucosamine infusion induces insulinresistance in normoglycemic but not in hyjwrglycemic conscious rats. Journal of Clinical Investigation 96: 132-140,1995,

ffl Rossetti L, Stenbit AE, Chen W: Peripheral but not hepatic insulin resistance in mice with onedisrupted allele of the glucose transporter type 4 (GLUT4) gene. Journal of Clinical Investigation 100; 1831-1839, 1997.

9 Rossini AA, Greiner DL, Friedman HP: Immnuopathogenesis of diabetes mellitus. Diabetes fleview1:43, 1993.

9 Saad MJ, Folli F, Araki E, Flashimoto N, Csermely P, Kahn CR: Regulation of insulin receptor,insulin receptor substrate-1 and phosphatidyiinositol 3-kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin, and dexamethasone. Molecular Endocrinology 8: 545-557, 1994.

9 Sakoda FI, Ogihara T, Anai M, Funaki M, hiukai K, Katagiri H: Dexaiiiethasone induced insulinresistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes 49: 1700-1708, 2000.

® Salmeron J, Ascherio A, Riinm EB: Dietary fiber, glyceniic load and risk of NIDDM in men.Diabetes Care 20: 545, 1997.

» Santamaria P, Utsugi T, Park B-J, Averill N, Kawazu S, Yoon JW: Beta cell cytoto.Kic CD8+ T cellsfrom non obese diabetic mouse use highly homologous T-ccIl receptor chain CDR3 sequences. Journal of Immunology 154: 2494, 1995.

Satoh MS, Lindahl T: Role of poly (ADP-ribose) formation in DNA repair. Nature 356: 356-358,1992.

a Satomi H, Umemura K, Ueno A, Hatano T, Okuda T, Noro T: Carbonic anhydrase inhibitors Irom thepericarps o f Punica granalitm [,. Biological and Pharmaceutical Bulletin 16(8): 787-790, 1993.

® Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV; Resistin/Fizz3 expressionin relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50: 2199-2202, 2001.

e Schein PS, O’Connell MJ, Bkom J: Clinical anti-tumour activity and toxicity of streptozotocin (NSC-85998). Cancer 34: 993-1000, 1974.

e Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF: A novel serum protein similar to Clq,produced exclusively in adipocytes. Journal of Biological Chemistry 270:26746-26749, 1995.

® Schmidt A, Mordliorst T, Nieger M: Investigation of a betainic alkaloid from Punica gnmahim.. Natural Product Research 19(5): 541-546,2005.

® Schnedl WJ, Ferber S, Johnson JH, Newgard CB: STZ transport and cytotoxicity. Specificenhancement in GLUT2-expressing cells. Diabetes 43: 1326,1333,1994.

® Schulze I, Gazith J, Gooding R: Hexokinase, Methods in Enzymology 9, W.A. Wood, AcademicPress, NY, p376, 1966.

Schubert SY, Lansky EP, Neeman I: Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and femiented juice flavonoids. Journal of Ethnopharmacology 66: 1 1-17, 1999.

Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, Heber D: In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enlianced in combination with other polyphenols as found in pomegranate juice. Journal of Nutritional Biochemistry 16(6): 360-367, 2005.

Seidner G, Alvarez MG, Yeh JI: GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood brain barrier hexose carrier. Nature GeneticslS: 188-191, 1998,

Sestili P, Martinelli C, Ricci D, Fratemale D, Bucchini A, Giamperi L, Curcio R, Piccoli G, Stocchi V: Cytoprotective effect of preparations from various parts of Piinica granatum L. fruits in oxidatively injured mammalian cells in comparison with their antioxidant capacity in cell free systems. Pharmacological Research [Epub ahead of print].doi:10.1016/j.phrs.2007.02.003; 2007 Feb 20.

Serni JJ, Klover PJ, Nowak L\, Zimmers TA, Koniaris, Furlanctto RW, Mooney RA: Suppressor of Cytokine Signaling-3 (SOCS-3), a Potential Mediator of Interleukin-6-dependeiit Insulin Resistance in Hepatocytes Journal OfBiological Chemistry 278: 13740-13746,2003.

Serreze DV, Chapman LID, Varnum DS: Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I dependant. Journal of Immunology 158: 3978, 1997.

Shein RS, Alberti KGMM, Williamson DLL Effects of streptozotocin on carbohydrate and lipid metabolism in the rat. Endocrinology 89: 827-834, 1971,

Shepherd PR, Abel ED, Kahn BB: Glucose transporters and pathophysiologic states. In; Diabetes Mellitus, A Fundamental and Ch'nical Text, Le Roith D, Taylor SI, Olefsky JM, (Eds,) 2'“' Edition, Lippincott-Williams & Wilkins, Philadelphia, USA, pp, 627-641, 2000,

Shoelson SE, White MF, Kahn OR: Tryptic activation of the insulin receptor. Journal of Biological Chemistry 263: 4852-4860, 1988.

Simbulan-Roscnthal CM, et al., The expression of poly (ADP-ribose) polymerase during differentiation-linked DNA replication reveals that it is a component of the multiprotein DNA replication complex. Biochemistry 35: 11622-11633, 1996.

Singh RP, Chidambara Miirthy KN, Jayaprakasha GK: Studies on the antioxidant activity of pomegi'anate (piinica granatum) peel and seed extracts using in vitro models. Journal of Agiicultural and Food Chemistry 50: 81-86, 2002.

Sohn DH, Kim YC, Oh SH, Park EJ, Li X, Lee BH: Hepatoprotective and free radical scavenging effects oiNelumbo nucifera. Phytomedicine 10(2-3): 165-169, 2003.

Spiegelman BM: PPAR-y:adipogenic regulation and thiazolidinedione receptor. Diabetes 47: 507- 514,1998.

Spranger J, Ki'oke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF: Adiponectin and protection against type 2 diabetes melhtus. Lancet 361: 226-228, 2003.

® Standaert ML, Bandyopadhyay G, Perez L, Price D, Galloway L, Poklepovic A, Sajan MP, Cenni V,Sirri A, Moscat J, Toker A, Farese RV: Insulin Activates Protein Kinases C-^ and C-A by an Autophosphoiylation-dependent Mechanism and Stimulates Their Translocation to GLUT4 Vesicles and Other Membrane Fractions in Rat Adipocytes. Journal of Biological Chemistry 274; 25308- 25316, 1999.

e Standaert ML, Galloway L, Karnam P, Bandyopadhyay G, Moscat J, Farese RV: Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes: potential role in glucose transport. Journal of Biological Chemistry 272: 30075-30082,1997.

® Standaert ML, Ortmeyer HK, Sajan MP, Kanoh Y, Bandyopadhyay G, Hansen BC, Farese RV:Skeletal Muscle Insulin Resistance in Obesity-Associated Type 2 Diabetes in Monkeys Is Linked to a Defect in Insulin Activation of Protein Kinase C-C/A//,. Diabetes 51: 2936-2943, 2002.

® Starr R, Willson TA, Viney EM, Muixay LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS,Metcalf D, Nicola NA, Hilton DJ: A family of cytokine-inducible inhibitors of signaling. Nature 387: 917-921, 1997.

e Stenbit AE, Tsao TS, Li J: GLUT4 heterozygous knockout mice develop muscle insulin resistanceand diabetes. Nature Medicine 3: 1096-1101, 1997.

® Stcnlof K, V/crnstedt I, Fjallman T, Wallenius V, Wallcnius K, Jansson JO: Interlcukin-6 levels in thecentral nervous system are negatively correlated with fat mass in ovei'weight/obese subjects. Journal of Clinical Endocrinology and Metabolism 88: 4379-4383, 2003.

o Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM: The hormone resistin linksobesity to diabetes. Nature 409: 307-312, 2001,

® Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY: A family of tissue-specificresistin-like molecules. Proceedings of National Academy of Science USA 98: 502-506, 2001a.

» Storlien LH, James DE, Burleigh KM, Chisholm DJ, Kraegen EW: Fat feeding causes widespread invivo insuhn resistance, decreased energy expenditure, and obesity in rats. American Journal of Physiology (Endocrinology and Metabolism) 14: E576-E583, 1986.

® Sudheesh S, Vijayalakshmi N: Flavonoids from Punica granatum - potential antiperoxidative agents.Fitoterapia 76(2): 181-186,2005.

® Suenaga K, Yoon JW: Association of beta cell-specific expression of endogenous retrovirus with thedevelopment of insulitis and diabetes in NOD mice. Diabetes 37: 1722, 1988.

e Sumner MD, Elliott-Eller M, Weidner G, Daubeninier JJ, Chew MH, Marlin R, Raisin CJ, Ornish D:Effects of pomegranate juice consumption on myocardial perlxision in patients with coronary heart disease. American Journal of Cardiology 96(6): 810-814, 2005.

e Surwit RS, Kulm CM, Cochrane C, McCubbin JA, Feinglos MN: Diet-induced type I! diabetes inC57BL/6Jmice. Diabetes 37,1163-1167, 1988.

s Suto ,r, Matsuiira S, Yamanaka H, Sekikawa K: Quantitative trait loci that regulate plasma lipid concentration in hereditary obese KK and KK-A^ mice. Biochimica Biophysica Acta 14^3, 385-395, 1999

® Suzuki K, Kono T: Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proceedings of National Academy Science USA 77: 2542-2545, 1980.

« Swanston-Flatt SK, Day C, Bailey CJ, Flatt PR; Traditional plant treatments for diabetes: studies in normal and streptozotocin diabetic mice. Diabetologia 33: 462-464, 1990,

® Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, Klip A: An inhibitor of p38 mitogen- activated protein kinase prevents insulin-stinmlated glucose transport but not glucose transporter traiislocation in 3T3-L1 adipocytes and L6 myotubes. Journal of Biological Chemistry 274: 15, 10071-10078, 1999.

9 Sykiotis GP, Papavassiliou AG: Minireview: Serine Phosphorylation of Insulin Receptor Substrate-1: A Novel Target for the Reversal of Insulin Resistance. Molecular Endocrinology 15: 1864-1869,2001.

® Tahiliani P, Kar A: Relative roles of some plant extracts in the regulation of serum thyroid hormonesand glucose concentrations in female rats, Journal of Medicinal and Aromatic Plant Sciences 22- 23(4A-1A): 64-69, 2000.

« Tajirna M, Yazawa T, Hagiwara K: Diabetes mellitus in cattle infccted with bovine viral dian'heamucosal disease virus. .louraal of Veterinary Medical Association 39: 616, 1992.

® Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakirra H, Hayakawa T, Terauchi Y, Ueki K, KaburagiY, Sato S: Insulin resistance and growth retardation in mice lacking insulin receptor substrate-I. Nature 372, 182-186, 1994.

® Tanaka T, Nonaka GI, Nishioka I: Punicatblin an ellagitannin from the leaves o f Punica gmnatum.Phytochemistry24(9): 2075-2078, 1985.

® Tanaka T, Nonaka GI, Nishioka 1: Tannins and related compounds XL. Revision of the structures ofpunicalin and punicalagin and isolation and characterization of 2-o galloylpunicalin from the bark of Punica gmnatum. Chemical and Pharmaceutical Bulletin 34(2): 650-655, 1986.

® Tanaka T, Nonaka GI, Nishioka I: Tannins and related compounds XLI. Isolation andcharacterization of novel ellagitannins punicacorteins A, B, C and D and punigluconin from the bark o f Punica granatum. Chemical and Phannaceutical Bulletin 34(2): 656-663, 1986a.

® Tanti J, Gremeaux T, Grillo S: Overexpression of a constitutively active form of phosphatidylinositol3-kinase is sufficient to promote Glut 4 translocation in adipocytes. Journal of Biological Chemistry 271: 25227-25232, 1996.

® Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA,Clark FT, Deeds J: Identification and expression cloning of a leptin receptor, OB-R. Cell 83: 1263- 1271, 1995.

a Taylor RJ, Bennet PH, LeGonidec G; The prevalence of diabetes raellilus in traditional-livingPolynesian population: the Wallis island survey. Diabetes care 6: 334, 1983.

® Terrettaz J, Jeanrenaud B: In vivo hepatic and peripheral insulin resistance in genetically obese (fa/fa)rats. Endocrinology 112: 1346-1351, 1983.

® Toker A, Meyer M, Reddy KK, Falck JR, Aiieja R, Aneja S, PaiTa A, Burns DJ, Balias LM, CantleyLC: Activation of protein kinase C family members by the novel polyphosphoinositides PtdIiis-3,4- P2 and PtdIns-3,4,5-P3. Journal of Biological Chemistry 269: 32358-32367,1994.

® Toniolo A, Onodera T, Jordon G: Virus-induced diabetes mellitus: Glucose abnormalities produced inmice by all six members of the Coxsackie B virus group. Diabetes 31: 496, 1982.

® Toumy ESAA, Rauwald HW: Two new ellagic acid rhamnosides from Ptmica granatum heartwood.Planta Medica 69(7): 682-684, 2003.

8 Trease GE, Evans WC: Textbook of Pharmacognosy, 12"' ed".: 437-442, 1985.

® Tseng CC, Zhang XY, Wolfe MM: Effect of GIP and GLP-l antagonists on insulin release in the rat.American Journal of Physiology 276: E l049-E l054,1999.

a Tsuboi H, Ikegami S, Ji ZS, Itou H, Oda M, Shin K: a-Glucosidase activity inhibitor. Patent no, WO2005041995; Kind A l; Date 2005-05-12 Patent written in Japanese. 2005.

® Tsuru M, Katagiri H, Asano T, Yamada T, Ohno S, Ogihara T, Oka Y: Role of PKC isoforms inglucose transport in 3T3-L1 adipocytes: insignificance of atypical PKC. American Journal of Physiology, Endocrinology and Metabolism 283: E338-E345, 2002.

® Ueki K, Kondo T, Kahn CR: Suppressor of cytokine signaling 1 (socs-1) and socs-3 cause insulinresistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Molecular and Cellular Biology 24: 5434-5446, 2004.

® Ukkola O: Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?European Journal of Endocrinology 147: 571-574, 2002.

® Ullrich A, Bell ,TR, Chen EY, Herrera R, Petruzzelli LM, Dull TJ, Gray A, CoussensL, Liao YiC,Tsubokawa M, Mason Ai Seeburg PH, Grunfeld C, Rosen OM, Ramachandran J: Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313:756-761,1985.

e Upton R, Widdowson P, Ishii S, Tanaka H, Williams G: Improved metabolic status and insulinsensitivity in obese fatty ifalfa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555. British Journal of Phannacology 125: 1708-1714, 1998.

e Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil OS: Protection from obesityinduced insulinresistance in mice lacking TNF-alpha function. Nature 389:610-614,1997.

® Vasconcelos LC, Sampaio FC, Sampaio MC, Pereira Mdo S, Higino JS, Peixoto MH: Minimuminhibitory concentration of adherence of Punica granatum Linn (pomegranate) gel against S. mutans, S. mitis and C, albicans. Brazilian Dental Journal 17(3):223-227,2006.

0 Vats V, Yadav SP, Grover JK: Ethanolic extract of Ocimum sanctum leaves partially attenuates streptozotocin-induced alterations in glycogen content and carbohydrate metabolism in rats. Journal of Ethnophamiacology 90: 155-60, 2004.

® Velloso LA, Eizirik DL, Karlsson FA: Absence of antibodies against glutamic acid decarboxylase (GAD) in non-obese diabetic (NOD) mouse and low expression of the enzyme in mouse islets. Clinical and Experimental Immunology 96: 129, 1994.

® Verdaguer J, Schmidt D, Amrani A; Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. Journal of Experimental Medicine 186:1663, 1997.

© Voravuthikunchai S, Lortheeranuwat A, Jeeju W, Sririrak T, Phongpaichit S, Supawita T: Effectivemedicinal plants against enterohaeniorrhagic Escherichia coli 0157: EI7. Journal ofEthnopharmacology 94(1): 49-54, 2004,

® Waddell ID, Zomerschoe AG, Voice MW, Burchell A: Cloning and expression of a hepatic microsomal glucose transport protein. Comparison with liver plasma-membrane glucose-transport protein GLUT 2. Biochemical Journal 286: 173-177, 1992.

e Wallenius K, Wallenius V, Sunter D, Dickson SL, Jansson JO: Intracerebroventricular interleukin-6treatment decreases body fat in rats. Biochemical and Biophysical Research Communications 293: 560-565,2002a.

® Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO: hiterleukin-6-deficient mice develop mature-onset obesity. Nature Medicine 8: 75-79, 2002.

® Wang JL, Nong Y, Jing MX: Effects of liensinine on haemodynamics in rats and the physiologic properties of isolated rabbit atria. Acta Pharmaceutica Sinica 27(12): 881-885, 1992.

0 Wang JL, Nong Y, Xia GJ, Yao WX, Jiang MX: Effects of linesinine on slow action potentials inmyocardium and slow inwai'd current in canine cardiac Purkinje fibers. Acta Pharmaceutica Sinica 28(11): 812-816, 1993.

• Wang B, Andre I, Gonzalez A. Interferon gamma impacts at multiple points during the progression of autoimmune diabetes. Proceedings pf National Academy of Science USA 94, 13844, 1997.

• Wang B, Gonzalez A, Iloglund P. Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes 47, 1207, 1998.

e Wang Q, Somwar R, Bilan PJ: Protein kinase B/Alct participates in GLUT4 translocation by insulin inL6 myoblasts. Molecular and Cellular Biology 19: 4008-4018, 1999.

9 Wang L, Yen JH, Liang HL, Wu MJ: Antioxidant effect of methanol extracts from lotus plumule andblossom (Nelumbo nucifera Gertn.). Journal of Food and Drag Analysis 11(1): 60-66,2003.

® Wang R, Wei Wang, Wang L, Liu R, Yi Ding, Du L: Constituents of the flowers of Piinica granatum.Fitoterapia 77(7-8):534-537, 2006.

® Ward KP, Galloway WH, Auchterlonie lA: Congenital cytomegalovirus infection and diabetes.Lancet 1: 497, 1979.

e Wassel G, Saeecl A, Ibrahim N, El-Eraqy W: Flavoiioids of Nebimbo micifera Gaertn. and biological evaluation. Egyptian Journal of Phamaceutical Sciences 37(1-6): 585-596, 1996.

® Watson RT, Shigematsu S, Chiang S-H, Mora S, Kanzaki M, Macara IG, Saltiel AR, Pessin JE: Lipid raft microdomain compartinentalization of TCIO is required for insulin signaling and GLUT4 translocation. Journal of Cell Biology 154, 829, 2001.

e Weber G, Lea MA, Fisher EA: Regulatory pattern of liver carbohydrate metabolizing enzymes;in.sulin as an inducer of key glycolytic enzymes. Enzymology Biology Clinics (Basel) 7, 11-24, 1966.

s Weide LG, Lacy PE: Low-dose streptozotocin-induced autoimmune diabetes in islet transplantationmodel. Diabetes 40: 1157, 1991.

e Weidmann P, Boehlen LM, de Courten M: Pathogenesis and treatment of hypertension associated with diabetes mellitus. American Heart Journal 125: 1498-1513, 1993.

® Wein RB: Streptozotocin: Review of its pharmacology, efficacy and toxicity. Cancer Treatment Rep 66c: 477-438, 1982.

® Weir GC, Clore EE, Zma-Chinsky CJ, Bonnier-Weir S: Islet secretion in new experimental model for non-insulin dependent diabetes. Diabetes and Metabolism Reviews 30: 590-595, 1981.

0 Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA:Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 86: 1930-1935, 2001.

a White MF, Kahn CR: The cascade of aiitophosphorylation in the b-subunit of the insulin receptor. Journal of Cell Biochemistry 39: 429, 1989,

0 Wliite MF, Shoelson SE, Keutmann H, Kahn CR: A cascade of tyi'osine autophosphorylation in the p- subunit activates the insulin receptor. Journal of Biological Chemistry 263: 2969-2980, 1988.

e WHO. www.who.int/diabetes 2005.

© WHO/Acadia. Rapport de la Journe Internationale de, diabetes 14 octobre, 1992.

B Wiese RJ, Mastick CC, Lazar DF, Saltiel AR: Activation of mitogen-activated protein kinase andphosphatidylinositol 3’-kinase is not sufficient for the hormonal stimulation of glucose uptake, lipogenesis, or glycogen synthesis in 3T3-L1 adipocytes. Journal of Biological Chemistry 270: 3442- 3446,1995.

® Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bemal D, Pons S,Shulman Gl, Bonner-Weir S, White MF. Disraption of IRS-2 causes type 2 diabetes in mice. Nature 391,900-904, 1998.

® Wogensen L, Lee MS, Sarvetnick N: Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. Journal o f Experimental Medicine 179: 1379, 1994.

® Wohaieb SA, Godin DV: Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rats. Diabetes 36: 1014-1018, 1987.

a WHO (World Health Organization). Expert committee diabetes mellitus. Technical Report Second Series. No.646, WHO, Geneva, p. 61, 1980.

s World Health Organization. Second report of the WHO expert committee on the diabetes mellitus. Technical Report Series No. 646. Geneva, Switzerland, 1980.

® Worm D, Vinten J, Staehr P, Henriksen JE, Handberg A, Beck-Nielson H: Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle fractions from NIDDM patients compared with control subjects. Diabetologia 39: 1208, 1996.

o Wu MJ, Wang L, Weng CY, Yen JH: Antioxidant activity of methanol e.xtract of the lotus leaf[Neliimbo mtcifera Gertn.). American Journal of Chinese Medicine 31(5): 687-698, 2003.

® Xiao J, Zhang Y, Ding L, Feng X, Wang J: Effects of isoliensinine on proliferation of porcinecoronary arterial smooth muscle cells induced by phenyleplnine. Yaoxue Xuebao 40(2); 105-110, 2005a.

e Xiao JH, Zhang JH, Chen HL, Feng XL, Wang Jl; Inhibitory effects of isoliensinine on bleomycin-induccd pulmonary fibrosis in mice. Planta Medica 71(3): 225-230, 2005.

0 Xiao JH, Zhang YL, Feng XL, Wang JL, Qian JQ: Effects of isoliensinine on angiotensin Il-inducedproliferation of porcine coronaiy arterial smooth muscle cells. Journal of Asian Natural Product Research 8(3):209-216, 2006.

® Yadav S, Vats V, Dhunnoo Y, Grover JK: Hypoglycemic and antihyperglycemic activity of Murrayakoenigii leaves in diabetic rats. Journal of Ethnophamiacology 82: 111-116, 2002.

® Yamamoto H, Uchigata Y, Okamoto H: Sti'eptozotocin and alloxan induce DNA strand breaks andpoly (ADP-ribose) synthetase in pancreatic islets. Nature 294: 284-285, 1981.

® Yang J, Clarke IF, Ester CJ, Young PW, Kasuga M, Holman GD: Phosphatidylinositol 3-kinase actsat an intracellular membrane site to enhance GLUT4 exocytosis in 3T3-L1 cells. Biochemical Journal 313: 125-131, 1996.

0 Ye JM, Patrick JD, Iglesias MA, Watson DG, Cooney GJ, Kraegen EW: Peroxisome proliferator-activated receptor (PPAR)-a activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats. Diabetes 50: 411-417, 2001.

® Yoon JW, Hee~Sook J; Role of virases in the pathogenesis of type 1 diabetes mellitus. In: DiabetesMellitus, A Fundamental and Clinical Text, LeRoith D, Taylor SI, Olefsky JM: eds. 2"“ Edition, Lippincott Williams & Wilkins, Philadelpliia, p419-430, 2000.

e Yoon JW: Pathogenesis of IDDM. Environmental factors. In: Pickup I, Williams G, eds. Textbook ofdiabetes, London: Blackwell scientific publications, 14.1,1997.

® Yoshizaki F, Komatsu T, Inoue K, Kanari R, Ando T, Hisamichi S: Survey of crade drugs effective ineliminating superoxides in blood plasma of mice. International Journal of Pharmacognosy 34(4): 277-282,1996,

e Young AA, Gedulin BR, Bhavsar S, Bodkin N, Jodka C, Hansen B, Denaro M; Glucose-lowering and insuiio-sensitizing actions of exendin-4: studies in obese diabetic {ob/ob, db/db) mice, diabetic fatty zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Diabetes 48: 1026-1034, 1999.

a Yu ,T, Hu WS: Effects of neferine on platelet aggregation in rabbits. Yaoxue Xuebao 32(1): 1-4,1997.

® Yu ZW, Buren ,f, Enerbiick S, Nilsson B, Saimielsson L, Eriksson JW: Insulin can enhance GLUT4gene expression in 3T3-F442A cells and this effect is mimicked by vanadate but counteracted by cAMP and high glucose - potential implications for insulin resistance. Biochimica Biophysica Acta 1535: 174-185,2001.

® Yusuph M, Mann J: A triglyceride from Punica granatum. Phytochemistry 44(7): 1391-1392, 1997.

e Zhang JZB, Yao X, Gao Y, Shong J: Antiviral activity of tannin from the pericarp of Punicagranatum L. against genital heq>es vims in vitro. Zhongguo Zhongyao Zazhi 20(9): 556-558, 576- 577, 1995.

® Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432,1994.

9 Zhao ZF, Zhang YL, Yu X, Feng XL, Wang JL: Effects of lotusine on cyclic nucleotide levels and contractile function in rat myocardium and rabbit corpus cavernosum. Zhongguo Yaolixiie Yu Duhxue Zazhi 16(3): 202-205,2002.

e Zierath JR, Galuska D, Nolte LA, Thorne A, Kristensen JS, Wallberg-Henriksson H: Effects o fglycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance. Diabetologia 37: 270-207, 1994.

s Zierath .IR, He L, Guma A, Wahlstrom EO, Klip A, Wallberg-Henriksson H: Insulin action onglucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 39; 1180-1189,1996.

a Zierath JR, Housebiecht I<L, Gnudi L, Kahn BE: High-iut feeding impairs insulin-stimulated GLUT-4 recruitment via an early insulin-signalling effect defect. Diabetes 46: 215-223,1997.

® Zimmet P, Alberti KGMM, Shaw .1: Global and societal implications of the Diabetes epidemic.Nature 414: 13,2001,

e Zimmet P: Diabetes epidemiology as a trigger to diabetes research. Diabetologia 42: 499-518, 1999.

e Zimmet P: Globalization, coca-colonization and the chronic disease epidemic: can the doomsdayscenario be averted? Journal of Internal Medicine 247: 301-310, 2000.

® Zimmet PZ, McCarty DJ, de Courten MP: The global epidemiology of non-insulin dependentdiabetes mellitus and the metabolic syndrome. Journal of Diabetes and Complications 11: 60-68,1997.

o Zimmet PZ: Kelly West Lecture 1991. Challenges in diabetes epidemiology: From West to rest.Diabetes care 15: 232, 1992.